Author: She Yunfeng

Source: Mobile Payment Network

Not long ago, Zhou Xiaochuan, vice chairman of Boao Forum for Asia, expressed several views on the development of digital RMB at the 2023 China Digital Finance Forum, two of which were very constructive and forward-looking.

Digital RMB is mainly based on account type.

Zhou Xiaochuan believes that the development of digital RMB is mainly based on account-based digital currency. In other words, token-based digital currency is a path that may have room for development, but the mainstream is account-based digital currency.

How to understand it? In fact, this is in great agreement with the current supervision on the path of promoting digital RMB.

The mobile payment network once published an article discussing the choice of digital RMB in the wallet path "Upgrade from value mode to account mode, and dual offline of digital RMB is not mainstream". We think that with the pilot implementation of digital RMB, account mode and quasi-account mode will become the mainstream in the future, and the value mode is only a supplement.

As we all know, digital RMB is compatible with three ways: account-based, quasi-account-based and value-based, and adopts variable denomination design to realize value transfer in the form of encrypted currency strings. Judging from the manifestations of digital RMB hard wallet, the quasi-account model is the mainstream at present, and the account model has also taken shape. Although the value model has technical conditions, there are still some problems in its real implementation.

Zhou Xiaochuan said that the choice of account type and token type is also closely related to the choice of centralized route. In the management mode, digital RMB needs to adhere to the two-tier operation system and centralized management concept.

Why should we adhere to the centralized management concept? Yi Gang, the former governor of the central bank, once said that because the digital currency of the central bank is the debt of the central bank to the public, it is necessary to ensure and strengthen the macro-prudential and monetary policy regulation functions of the central bank and maintain the original transmission mode of monetary policy.

In the two-tier operation structure, the first layer is centralized management, which is similar to that the central bank must know how much circulating cash it has issued and how much digital currency it has issued. The transfer and transaction activities between customers are on the second floor, and a large amount of customer information is stored on the second floor, that is, industry, agriculture, China, construction, communication or WeChat Alipay. They are obliged to be responsible for privacy protection, anti-money laundering and anti-terrorism financing, and only report the necessary information to the People’s Bank of China.

From this perspective, account-based centralized management is a necessary condition, and the central bank must have the right to manage the digital RMB as a whole. However, if a large number of token-based digital RMB with value model are adopted, the central bank will have a blank window for its management, which has certain security risks. Therefore, before the official launch, such security issues must be controlled to a minimum, and the value model digital RMB that is not under the management of the central bank after the official launch needs to be controlled within a certain range.

Therefore, quasi-account and account-mode wallets are all manifestations of account-based digital RMB, which will be the main development direction of digital RMB in the future. As a token-based development path, value mode still needs to be explored as a supplementary form.

The price system needs to be set under the two-tier operation

Zhou Xiaochuan believes that under the two-tier operation system, policy-making should make the digital payment system survive independently, and a price system should be set up so that the digital payment system can charge for services. In fact, the rate can be very low and the impact on customers is quite small. If there is no charging mechanism, it will lead to cross-subsidies and cross-sales, and payment system service providers will focus on other aspects that should not be paid attention to.

Digital RMB adopts a two-tier operation system, one of the important reasons is to mobilize the enthusiasm of market institutions such as commercial banks to the greatest extent. The central bank issues digital RMB, but not directly to residents and corporate customers. Instead, it issues digital RMB to operating institutions, which serve customers directly as operators.

Yi Gang once wrote that the two-tier operation is conducive to making full use of the existing resources, talents, technology and other advantages of commercial organizations, and promoting innovation and competition through market-driven. In terms of business resources, commercial banks and technology companies have mature IT facilities and huge user base. In terms of human resources, commercial banks and technology companies also have sufficient talent reserves. The central bank mainly carries out top-level design, as well as legal norms and regulatory standards. After the top-level structure, legal norms and regulatory requirements are designed, services are handed over to the market to play a decisive role in the allocation of resources by the market. Two-tier operation helps to spread risks. The central bank does not presuppose the technical path and remains open. Different institutions can explore different technical paths and realize system optimization through competition.

However, in the pilot stage, the design of such optimal allocation of resources seems to have a big gap with the market development, and the most important reason is the "incentive mechanism" problem.

At present, the core of the two-tier operation system is the operation organization, which has the largest investment in personnel and property and the highest cost, but has no direct income. The operation of digital RMB has become a way for operating institutions to obtain customers, which is not conducive to the promotion and development in the later period.

The characteristic of digital RMB payment is settlement, which is indeed conducive to the efficient realization of the payment process, but it also reduces the participation of the payment process and even cuts off the interest rate acquisition space.

As a large number of participants in the 2.5-tier, it has a high degree of overlap with the 2-tier institutions in the non-operational work of digital RMB. At present, the 10 operating institutions are commercial banks themselves, and they have a certain competitive relationship with the 2.5-tier commercial banks in terms of business and customer base. The 2-tier institutions have squeezed the 2.5-tier business space by virtue of their roles as wallet brands and operating institutions, which seems to affect the enthusiasm of small and medium-sized banks in the pilot process.

At present, there are more and more institutions participating in the pilot project of digital RMB. The 2.5-tier institutions lack clear and standardized roles, division of responsibilities and information protection, and there is no profit point. The participation enthusiasm of the 2.5-tier institutions in most pilot areas is very limited.

Therefore, in the view of mobile payment network, under the two-tier operation system, the sustainable development of digital RMB in the future can not be separated from the perfect "business model", on the one hand, it lies in the cooperation between various institutions at different levels, on the other hand, it lies in the respective functions of different institutions and the income points under their participation.

tag

As for whether "charging" will affect the "zero handling fee" feature of digital RMB, in fact, users can rest assured that the exchange and redemption of digital RMB will be "zero handling fee" for both users and merchants now and in the future. However, after the future business model is perfected, it is unclear whether the rate income of institutions will be passed on to users and merchants under the price system!

　　editorial comment/note

　　"When the medical profession is faced with a major epidemic, people are most concerned about whether there are specific drugs. It seems that this is the only criterion for formulating a response plan. Just like this time, there is no specific medicine so far. What should I do? " Pan Yi, a professor and doctoral supervisor at Guangzhou University of Traditional Chinese Medicine, thinks that we can change our way of thinking from "whether there are specific drugs" to "whether there are specific treatment ideas". For example, Chinese medicine can adjust and improve patients’ immune function, so that they can cope with the virus, thus achieving curative effect.

　　On April 15th, Guang ‘anmen Hospital of Chinese Academy of Traditional Chinese Medicine welcomed 15 medical staff from Guang ‘anmen Hospital, the first batch of Chinese medical aid team in Hubei, to go home.

　　Great epidemics give a good prescription. Traditional Chinese medicine "three drugs and three parties", represented by Jinhua Qinggan Granule and Qingfei Paidu Decoction, plays an important role in the clinical treatment of the epidemic, and Chinese medicine has been highly concerned by all walks of life. Many experts said that the prevention and treatment of infectious diseases by Chinese medicine pays attention to enhancing the human body’s own resistance and repair ability, and pays attention to maintaining the overall balance, which makes Chinese medicine have its own place in dealing with infectious diseases with unclear causes and lack of vaccines and special drugs.

　　Juck Zhang Zhong, a researcher at the China Institute of Science and Technology Information and vice chairman of the Chinese Philosophy Committee of the Chinese Society of Philosophy History, said: "Chinese medicine has always been a part of the treasure house of Chinese civilization, and it should be a new trend to distinguish between Chinese medicine and Chinese medicine."

Part I: "Three Drugs and Three Parties" vs. COVID-19

　　"We didn’t find a specific medicine, but we have an effective plan." In the fight against COVID-19, Chinese medicine represented by "three medicines and three parties" is an effective scheme to fight the epidemic. "Three drugs and three parties" have played an important role in preventing mild illness from turning into severe illness, severe treatment and patient rehabilitation.

　　The whole course of application, more than 90% patients use traditional Chinese medicine.

　　Mr. Yang, a 68-year-old critically ill patient in COVID-19, has a history of diabetes for three years. He once had a high fever of 39 degrees Celsius, which was diagnosed as wind-warm disease and pathogenic invasion of lung-health syndrome by TCM. In Hubei Provincial Hospital of Traditional Chinese Medicine, the treatment is mainly to clear away heat and toxic materials, dispel wind and relieve exterior syndrome, and at the same time, western medicine is given anti-infection, anti-virus and symptomatic support treatment. After 14 days of treatment, the nucleic acid test was negative twice, and CT showed that the lesions in both lungs were obviously reduced. Mr. Yang was cured and discharged.

　　"Without specific drugs, the war epidemic should play the role of traditional Chinese medicine." After the outbreak of COVID-19, state administration of traditional chinese medicine set up five TCM medical teams consisting of 770 medical staff to help Wuhan urgently, and 29 provinces, autonomous regions and municipalities across the country sent more than 4,900 TCM medical staff to help Hubei, accounting for about 13% of the total number of medical staff assisting Hubei, including 3 academicians and hundreds of experts.

　　"Early intervention of Chinese medicine has stabilized people’s hearts and reduced new cases, which has played a role in preventing and controlling the spread of the epidemic from the source." The person in charge of the Comprehensive Department of Traditional Chinese Medicine of Hubei Provincial Health and Wellness Committee said. At the early stage of the epidemic, Hubei promptly distributed traditional Chinese medicine to the isolated personnel, frontline medical staff and community workers in centralized isolation points, and distributed 440,000 pneumonia prevention prescriptions and 190,000 Chinese patent medicines. The isolated personnel should "take all the traditional Chinese medicine".

　　Shelter Hospital is the key measure to realize all patients in COVID-19 should be treated. Zhang Boli, academician of China Academy of Engineering and president of Tianjin University of Traditional Chinese Medicine, said: "In Fangcang Hospital, it is our goal that mild diseases do not turn into severe ones, so we have adopted comprehensive treatment of traditional Chinese and western medicine, in addition to taking decoction or Chinese patent medicine, there are also comprehensive treatments such as massage, scraping and application."

　　A total of 11,740 people were admitted to 16 shelter hospitals in Wuhan. Each shelter hospital was equipped with 4-8 Chinese medicine experts, and four kinds of Chinese patent medicines, such as Chinese medicine decoction and Jinhua Qinggan granules, were distributed simultaneously. The utilization rate of Chinese medicine was 99.93%.

　　On February 24th, Chinese pharmacists labeled the decoction "Qingfei Paidu Decoction" in the decocting room of the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine.

　　Jiangxia Fangcang Hospital is a specialized Chinese medicine Fangcang Hospital. Here, the medical staff adopted a comprehensive treatment method of traditional Chinese and western medicine, with all patients covered with Chinese medicine decoction, and also cooperated with traditional Chinese medicine therapies such as moxibustion, supplemented by Tai Ji Chuan and Baduanjin, and made a set of Chinese medicine "combination boxing". None of the 564 patients in Jiangxia Fangcang Hospital became severe.

　　"The comprehensive treatment of traditional Chinese medicine has significantly reduced the proportion of mild illness to severe illness, which is the key to our victory." Zhang Boli said.

　　For severe patients, western medicine is the main method, and the combination of Chinese and western medicine is adopted. In Jinyintan Hospital, Hubei Hospital of Integrated Traditional Chinese and Western Medicine and Thunder God Mountain hospital, Chinese medicine also participated in the whole process. Zhang Boli said: "Shengmai injection and Shenmai injection have an effect on stabilizing patients’ oxygen saturation and improving oxygenation level; Tanreqing injection, Reduning injection and antibiotics have synergistic effect; Xuebijing is effective in inhibiting inflammatory storm and controlling the progress of the disease. Critical care, integration of Chinese and Western medicine and reduction of mortality are the core of our success. "

　　When patients just leave the hospital, their physical function is often weak, sometimes they are weak and cough, and their immune function has not been completely restored. Chinese medicine is also actively providing rehabilitation programs. On February 24th, the rehabilitation clinic of Wuhan Hospital of Traditional Chinese Medicine was opened. As of April 11th, 862 online and offline patients have been provided with rehabilitation treatment.

　　According to the data provided by Yu Yanhong, Party Secretary of state administration of traditional chinese medicine, 74,187 people, accounting for 91.5%, used traditional Chinese medicine in COVID-19. Among them, 61,449 people in Hubei Province used Chinese medicine, accounting for 90.6%. From preventive medication in isolated population, to the diagnosis of mild and severe patients, and then to later rehabilitation, the participation of traditional Chinese medicine is wide, deep and highly concerned, and the total effective rate of traditional Chinese medicine is over 90%.

　　Old drugs are used newly, and the clinical effect of "three drugs and three parties" is obvious

　　"Traditional Chinese medicine is a holistic medicine that integrates prevention, treatment and rehabilitation. It has a long history and is a household name. When encountering major epidemics, it will look for solutions." Yu Yanhong said. In recent years, viral respiratory infectious diseases have occurred frequently, and Chinese medicine has accumulated experience in treating SARS, H1N1 and other diseases.

　　In the absence of specific drugs and vaccines for the epidemic in COVID-19, experts combined with clinical practice, summed up the experience of traditional Chinese medicine in treating viral infectious diseases, explored ancient classic prescriptions, and screened out a number of effective prescriptions represented by "three drugs and three parties".

　　Jinhua Qinggan Granule was developed during the epidemic of H1N1 in 2009. It is made up of Maxing Shigan Decoction in Treatise on Febrile Diseases by Zhang Zhongjing in Han Dynasty and Yinqiao Powder in Treatise on Febrile Diseases by Wu Jutong in Qing Dynasty. Its main functions are dispersing wind, dispersing lung, and clearing away heat and toxic materials. According to Academician Zhang Boli, a group of 102 clinical controlled studies in Wuhan showed that Jinhua Qinggan Granule, compared with the control group, reduced the proportion of patients with mild and common diseases in COVID-19 by 2/3, and shortened the fever-relieving time by 1.5 days.

　　Jiangxia Shelter Hospital, located in Dahuashan Outdoor Sports Center, Jiangxia District, Wuhan, is the first shelter hospital in Wuhan that focuses on traditional Chinese medicine.

　　Lianhua Qingwen is based on the classic prescriptions, which was created during SARS in 2003. Its main functions are also to clear away the plague and detoxify, spread the lung and relieve heat.

　　A study jointly attended by 23 hospitals in 9 provinces and cities in China shows that Jinhua Qinggan and Lianhua Qingwen, two old drugs, are effective in treating mild and common types in COVID-19.

　　Xuebijing injection is also a new use of old medicine. Professor Qiu Haibo, vice president of Zhongda Hospital affiliated to Southeast University, said that Xuebijing could reduce the death rate of severe pneumonia by nearly 8.8 percentage points after it was used in clinic at the end of January according to the evaluation system of western medicine. "Xuebijing injection may be a very important therapeutic drug in the treatment of severe and critical patients." Qiu Haibo said.

　　"Although Chinese medicine and western medicine belong to two different medical systems and have different perspectives on health and disease, they are both based on the fact of clinical efficacy." Huang Luqi, academician of China Academy of Engineering and president of Chinese Academy of Traditional Chinese Medicine, thinks.

　　Among the three parties, the first one is Qingfei Paidu Decoction, which comes from Maxing Shigan Decoction, Shegan Mahuang Decoction, Xiaochaihu Decoction, Wuling Powder, etc. It is a light, common, heavy and critical general prescription. 57 cases of severe patients were treated with combination of traditional Chinese and western medicine, and none of them became critical. After two courses of treatment (6 days), 53 cases of lung lesions showed different degrees of shrinkage and absorption.

　　Xuanfei Baidu prescription is condensed on the basis of classic prescriptions such as Maxing Shigan Decoction, Maxing Yigan Decoction, Keli Jujube Xiefei Decoction and Qianjin Weijing Decoction. In Wuhan Hospital of Traditional Chinese Medicine, Hubei Hospital of Integrated Traditional Chinese and Western Medicine and Jiangxia Fangcang Hospital, a cohort study of 500 patients treated with this prescription showed that the symptoms of fever, cough and fatigue were obviously alleviated in light and ordinary patients, and none of them became severe.

　　On the basis of the prescription recommended by the national diagnosis and treatment plan, the medical team of Chinese Academy of Traditional Chinese Medicine was optimized in Jinyintan Hospital in combination with clinical practice. After using this prescription, 75 critically ill patients enrolled in the clinical controlled trial in Jinyintan Hospital showed obvious improvement in lung inflammation and clinical symptoms diagnosed by CT, and the nucleic acid turned negative and the hospitalization time was shortened by an average of 3 days.

　　Liu Qingquan, president of Beijing Hospital of Traditional Chinese Medicine, believes that Chinese medicine has been treating infectious diseases for thousands of years and has formed a relatively mature scientific law. The treatment of infectious diseases mainly focuses on three treatment methods-clearing heat, eliminating dampness and detoxifying. The causes of various infectious diseases are different, and the three treatments are different. In this process, traditional Chinese medicine has produced classic prescriptions. "In view of a new disease like COVID-19, the new use of old drugs is really to be upright and innovative, and to treat diseases." Liu Qingquan said.

　　According to the report of the World Health Organization, in COVID-19, about 13% are severely ill and about 7% are critically ill. After the treatment of integrated traditional Chinese and western medicine, the weight transfer rate of Wuhan Fangfangcang Hospital is between 2% and 5%.

　　After the big exam, can Chinese medicine usher in opportunities?

　　On January 25th, 61-year-old Mr. Qian was sent to Guanggu Hospital of Hubei Provincial Hospital of Traditional Chinese Medicine for persistent high fever and dyspnea, and was diagnosed as COVID-19. Because of his many basic diseases and rapid development, he was declared critically ill twice. The team of Associate Professor Li Gang, director of the emergency department, treated him with integrated traditional Chinese and western medicine for more than 10 days, and Mr. Qian recovered and was discharged from hospital on February 17.

　　"Chinese medicine treatment runs through the whole course of Mr. Qian’s treatment." Li Gang introduced that the weapons of traditional Chinese medicine are far more than "three drugs and three parties". According to different course of disease, prescriptions of "Pneumonia No.2", "Pneumonia No.3", "Pneumonia No.4" and "Pneumonia No.5" are prescribed. After leaving the hospital, Mr. Qian continued to take the "Pneumonia No.5" decoction for some time.

　　Mr. Huo, a 68-year-old critically ill patient, was discharged from the hospital on the same day as Mr. Qian. The course of the disease is different between them, and the use of traditional Chinese medicine is also slightly different during the treatment. "After Mr. Huo was admitted to the hospital, he first used anti-infective western medicine to control the inflammatory reaction, and then used Chinese medicine for symptomatic conditioning." Li Gang said.

　　Yi Feng, head of the Fifth Department of Pulmonary Diseases of Hubei Provincial Hospital of Traditional Chinese Medicine, said that the participation of Chinese medicine in the treatment can promote the absorption of drugs in lung lesions and reduce or even solve complications and sequelae such as lung tissue injury and pulmonary fibrosis. At present, all patients who have been discharged after follow-up report that their condition is stable and they are gradually recovering.

　　Chinese medicine embodies China’s wisdom. Liu Qingquan said that when there was no specific western medicine, traditional Chinese medicine used the traditional wisdom of "encircling Wei to save Zhao". Through the adjustment of traditional Chinese medicine, the human environment in which the virus lived was changed from suitable to unsuitable, and the virus could not stay and left.

　　Qiu Haibo is an ICU doctor with a western medicine background. He believes that most western medicines are chemical drugs, and they are often treated for a certain target, while traditional Chinese medicine is a multi-target treatment. "Chinese medicine is more like teamwork and multi-point intervention." Qiu Haibo said that in view of the efficacy of traditional Chinese medicine, more and more internationally recognized evidence-based medicine methods are being used to evaluate the efficacy, and more and more traditional Chinese medicines, proprietary Chinese medicines and traditional Chinese medicine injections are using internationally recognized randomized controlled research methods to evaluate the efficacy.

　　"Although we don’t have a specific medicine, Chinese medicine has an effective plan. The treatment of integrated traditional Chinese and western medicine is the highlight of our Chinese program. " Zhang Boli said.

　　In the history of China, there were more than 300 preliminary statistics of epidemic diseases with a certain scale. Many Chinese medicine classics, including Treatise on Febrile Diseases and Treatise on Epidemic Febrile Diseases, were formed after the great epidemic, and accumulated very rich experience in fighting epidemic diseases. Professor Wang Wei, vice president of Beijing University of Chinese Medicine, believes that deep excavation from it has many important values at present and in the future, which cannot be discarded.

　　"In history, every epidemic is a big exam. After these big exams, Chinese medicine has accumulated rich experience and formed excellent classic prescriptions." Fan Heng, director of the Department of Traditional Chinese Medicine of the Union Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology, said that this epidemic is both a big test and an opportunity for the modernization of traditional Chinese medicine. However, he believes that Chinese medicine is still not paid enough attention. During the SARS in 2003, Chinese medicine also played a very important role, but after that, it "retired" and did not attract enough attention from the society. After this epidemic, we should rethink how to give full play to the role of traditional Chinese medicine, how to promote the modernization of traditional Chinese medicine, and combine traditional Chinese and western medicine to improve the curative effect.

　　Wang Wei believes that syndrome differentiation and treatment of traditional Chinese medicine is very unique, which is very different from modern medicine. He suggested that in the future, in the deployment of major national science and technology projects, the scientific laws of syndrome differentiation and treatment should be further studied, which will play a very important role in the development of Chinese medicine. (Reporter Pi Shuchu, Li Changzheng)

Medium-length: prejudice is the biggest obstacle

　　In the prevention and control of COVID-19 epidemic, the intervention of traditional Chinese medicine is a bright spot. Traditional Chinese medicine has not only gained more recognition in China, but also played a unique role in the global anti-epidemic.

　　In recent years, the development of traditional Chinese medicine has become a national strategy, which is favored by more and more people. However, the controversy about traditional Chinese medicine on the Internet has not diminished. How to form a good atmosphere of "believing in, loving and using Chinese medicine" in the whole society still has a long way to go.

　　Great epidemics give a good prescription.

　　"Xiaochaihu preventive prescription" is suitable for susceptible people in COVID-19. Making tea with Guanzhong is helpful for epidemic prevention, and "Ai Cang San" made of Artemisia argyi, Rhizoma Atractylodis and Radix Angelicae Dahuricae can be called "disinfectant in Chinese medicine" … Since the outbreak of COVID-19, some Chinese medicine epidemic prevention tricks have become popular at home and abroad because of their simplicity and effectiveness.

　　On April 22, China went to the Malaysian anti-epidemic medical expert group to video connect with people from Chinese medicine circles all over Malaysia.

　　"In the view of Chinese medicine, it is very important to prevent COVID-19 and improve your immunity." Li Tingquan, head of the provincial expert group of Chinese medicine on epidemic prevention and control in COVID-19, Shanxi Province, and president of the Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, said.

　　During the epidemic period, some hospitals opened a column of TCM health preservation, and some simple methods of TCM epidemic prevention were popular. Zhang Junfeng, the attending physician of the Classic Prescription Research Office of the Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, recommended "Ai Cang San" for epidemic prevention at home. On the hospital’s WeChat platform, Zhang Junfeng demonstrated the specific production method through video, which had a lot of interaction with the public.

　　Shanxi Provincial Hospital of Traditional Chinese Medicine has also introduced a preventive prescription of traditional Chinese medicine for COVID-19. "On the hospital’s WeChat platform, there are also many people who consult and purchase preventive prescriptions. After the overseas epidemic, the sales of preventive prescriptions once rebounded slightly. " Wang Shiwei, director of pharmacy department of Shanxi Provincial Hospital of Traditional Chinese Medicine, said.

　　There are so many misunderstandings.

　　Traditional Chinese medicine (TCM) has formed a unique view of life, health, disease and prevention in the practice of war and epidemic for thousands of years. TCM diagnosis and treatment focuses on "sick people", not just "human diseases"

　　In addition to the outstanding contribution in the prevention and treatment of COVID-19, Chinese medicine has also played a unique role in the prevention and treatment of SARS, influenza A (H1N1) and human infection with H7N9 avian influenza. However, the controversy over Chinese medicine on the Internet has not diminished, and it has become one of the topics of "explosion" in the current society. Influenced by extreme views, some people’s misunderstanding of Chinese medicine is getting deeper and deeper, and even the phenomenon of "blackening" Chinese medicine has appeared.

　　There is a prejudice that Chinese medicine has a slow curative effect. "Chinese medicine pays attention to prevention, but it is not wise after the event. Chinese medicine is not a slow doctor, such as acupuncture. If you go down with a needle, the effect will be particularly fast. " Liu Yang, deputy director of the Humanities Health Center of Shanxi University of Traditional Chinese Medicine, said.

　　There is also a view that Chinese medicine is unscientific. Pan Yi, a professor and doctoral supervisor at Guangzhou University of Chinese Medicine, believes that the bias of this view lies in: First, medicine, especially Chinese medicine, is not a pure natural science; Secondly, reductive science is not the whole of natural science, and it is typical to generalize by replacing all scientific criteria with reductive scientific criteria. Ignoring the limitation of reductionism thinking as the only basis for judging whether Chinese medicine is scientific or not is hard to say that it does not violate the basic attitude of scientific objectivity and justice.

　　On April 3rd, in Boao Super Chinese Medicine Hospital, Hainan, Chinese medicine felt the pulse of a patient.

　　Zhang Huailiang, a professor at the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, believes that there are many reasons for the misunderstanding of Chinese medicine, some of which are because some people in the society swindle and cheat under the banner of Chinese medicine; Some are because some Chinese medicine practitioners are not realistic and exaggerate the efficacy of Chinese medicine; Some deliberately find fault and make money by accusing Chinese medicine practitioners of smashing traffic; Others, wearing colored glasses, totally deny the traditional culture of China, and Chinese medicine has also become the target of attack.

　　Experts said that the green health concept of traditional Chinese medicine, the overall concept of harmony between man and nature, the diagnosis and treatment mode of syndrome differentiation and comprehensive treatment, and the use of natural prevention and treatment methods are particularly in line with the development trend of future medical transformation from disease medicine to health medicine and medical model from biomedicine to "bio-psychological-social" model.

　　De-generalization and de-mystification

　　In recent years, the revitalization and development of traditional Chinese medicine has ushered in a historic opportunity with favorable weather, geographical location and human harmony.

　　"Chinese and Western medicine have different theories and methods. It is the highlight of China’s characteristic medical and health system to advocate equal emphasis, parallelism and combination of Chinese and Western medicine and learn from each other’s strengths." Wang Xueshi, winner of Bethune Medal and former president of Yonghe County Hospital of Traditional Chinese Medicine in Shanxi Province, said that Chinese medicine should first be confident, self-reliant and self-respecting. Only when the medical team learns, understands and loves Chinese medicine can we promote the recognition and acceptance of Chinese medicine by the whole society, improve the medical system with China characteristics and stand in the forefront of world medicine.

　　The establishment of cultural identity of traditional Chinese medicine is the foundation of developing traditional Chinese medicine. "To popularize the essence of Chinese medicine culture, we must promote it into primary and secondary schools." Wang Xueshi believes that educating children from an early age, loving national culture and advocating Chinese medicine knowledge are conducive to establishing a sense of self-confidence in national culture and Chinese medicine culture. The course focuses on the contribution of traditional Chinese medicine in the history of the development of the Chinese nation and the benevolence of ancient medical experts. Starting from an early age is the first and very important step, and it is also one of the best strategies to solve the problem between doctors and patients.

　　Liu Yang and other experts said that we should be alert to some generalization, vulgarization and mystification tendencies in the process of inheritance and development of traditional Chinese medicine. It is a huge project to sort out, distinguish and discard the dross of Chinese medicine culture, which cannot be completed by one person and needs the joint efforts of the Chinese medicine community.

　　"The basic skills of ancient Chinese medicine masters are very solid. I am familiar with the classics of doctors, and now I am not doing well in this respect. At present, it is a big problem not to study and study less. " Wei Zhonghai, a special allowance expert of the State Council and a famous doctor in Shanxi, suggested that young people should be motivated to learn classic works of traditional Chinese medicine, and a group of backbones should be trained from them.

　　Zhang Huailiang believes that improving the social identity of Chinese medicine depends on the modernization of Chinese medicine, which requires not only maintaining the distinctive advantages of Chinese medicine, but also actively using modern science and technology, extensively absorbing the latest achievements of psychology and other disciplines, and building a scientific and technological innovation system that conforms to the characteristics of Chinese medicine. (Reporter Liu Xiangyu, Liu Huai)

Interview: Philosophical Debate of Traditional Chinese Medicine

　　Richard Preston wrote in Blood Plague: "There is only one flight between civilization and virus." The current COVID-19 epidemic has swept the world with faster and fiercer steps. In this war between human beings and viruses, every effective blocking result will save more people from the virus. Traditional Chinese medicine has played an important role in this epidemic, and it has become China’s characteristic and China’s plan for epidemic prevention and control. To this end, the reporter interviewed three experts in Chinese medicine philosophy to get a glimpse of the present and future of Chinese medicine from the perspective of "philosophy".

　　Zhang Daning: The Due Contribution of Philosophical Debate

　　Talking about the current environment faced by TCM, Zhang Daning, an academician of the International Eurasian Academy of Sciences, a famous nephrologist in China and the founder of TCM nephrology, said frankly: "TCM is much more difficult now than in the era of Zhang Zhongjing and Li Shizhen. At that time, it was a monopoly economy with one business, but now it is a market economy with two businesses. Modern patients often seek medical treatment from western medicine first, and then from Chinese medicine if they can’t be cured, which leaves difficult diseases to Chinese medicine. These are the problems faced by Chinese medicine at present. " He believes that the current Chinese medicine should make more contributions by taking advantage of the situation.

　　Contribution to medical ideas. Although Chinese medicine was formed more than 2000 years ago, many concepts are scientific and advanced so far. Such as the concept of "certificate". The medical system with "syndrome" as the core is the fundamental feature and advantage of traditional Chinese medicine. It is the analysis, induction and generalization of abnormal life activities of human body from the perspective of the unity of man and nature, and it is the supplement and revision of the concept of "disease" in modern medicine, from which traditional Chinese medicine forms the characteristics of syndrome differentiation and treatment. Further development of this concept will not only greatly improve the effect of disease prevention and treatment, but also deepen the understanding and understanding of diseases and all abnormal life activities of the human body.

　　"Harmony between man and nature" is an advanced philosophical thought in ancient China, which shows that man and nature are an organic whole, including seasons, climate, day and night, geography and society, which will affect normal and abnormal life activities of human body. Different methods should be adopted for treatment and health preservation according to different seasons and climates.

　　Contribution to the treatment of diseases. Zhang Daning thinks that the proportion of TCM treatment is different for different types and stages of diseases, but it is obviously incorrect to think that TCM treatment plays an "auxiliary role" in the treatment of all diseases. For example, traditional Chinese medicine plays a very important role in the treatment of nephropathy, especially chronic kidney diseases, at least, it is "half of the rivers and mountains." Other diseases, such as the application of prescriptions for promoting blood circulation and removing blood stasis in cardiovascular and cerebrovascular diseases, the treatment of chronic digestive tract diseases, and some diseases that Chinese medicine considers as "deficiency syndrome" and "depression syndrome", are all promising. The view that traditional Chinese medicine is only a "preventive medicine" is obviously inaccurate. Traditional Chinese medicine is a complete medicine that can treat both the sick and the untreated. Only by understanding the sick can we talk about the preventive medicine.

　　The intelligent decocting assembly line of East China Medicine Decocting Service Center, which was filmed on February 19th. The assembly line can accommodate more than 480 decocting barrels per hour and simultaneously decoct Xu Yushe.

　　Contribution to disease prevention, health preservation and rehabilitation. Zhang Daning believes that disease prevention, health preservation and rehabilitation are the strengths of traditional Chinese medicine. It is not only "preventing and treating diseases and protecting health", but more importantly, "improving people’s overall quality and quality, achieving the purpose of physical and mental health and prolonging life". In addition, Chinese medicine has rich experience in sequelae of cerebrovascular disease and orthopedic rehabilitation, and in preventing epidemics and infectious diseases.

　　Contribution to traditional Chinese medicine. Traditional Chinese medicine is a huge treasure-house, and Compendium of Materia Medica, Newly Revised Materia Medica, and Materia Medica for Emergency in Classics and History are all treasures of traditional Chinese medicine. Since the mid-20th century, scholars from all over the world have studied the "effective components" of traditional Chinese medicine, and made some significant achievements. It was under the guidance of his father-in-law who was a famous pharmacologist, Chen Kehui, who extracted ephedrine from Chinese traditional medicine Ephedra.

　　As for the broader study of "prescription composition", it is another treasure house of traditional Chinese medicine. According to incomplete statistics, there are tens of thousands of prescriptions recorded in ancient books alone. If great achievements can be made in this field, it will bring brand-new progress to world medicine.

　　Wu Kefeng: The Reason for Questioning Philosophical Debate

　　Wu Kefeng, a professor at the School of Philosophy of Nankai University and vice chairman of the Chinese Philosophy Committee of the Chinese Society of Philosophy History, believes that there are still people who are questioning the efficacy of Chinese medicine, which is closely related to the understanding of the cultural background and philosophical background of the survival of Chinese medicine.

　　Changes in living environment. The cultural background of TCM is China’s philosophy, and TCM is an integral part of China’s philosophy and China’s culture. At the same time, it is medicine itself, and the most important problem it faces and needs to solve is disease. The existence of traditional Chinese medicine needs to be supported by a suitable cultural and philosophical background. The cultural environment in which traditional Chinese medicine exists today is very different from that in ancient times.

　　The way of thinking changes. The key to the debate on the retention or abolition of TCM is that there is a problem in philosophical theory and thinking mode, that is, the western thinking mode that emphasizes analysis and demonstration is regarded as the only scientific thinking mode. Traditional Chinese medicine was originally born in the struggle between the ancients and diseases in China, but it quickly improved its level of understanding with the help of China’s ancient philosophy, and was constantly influenced by China’s philosophy to open the way to expand its own rational consciousness.

　　On the essence of the dispute between China and the West. To have an all-round understanding of traditional Chinese medicine needs to be understood from a philosophical and cultural perspective. The essence of the dispute between Chinese and western medicine is the dispute between Chinese and western philosophy and culture, and it is a question of cultural self-confidence and cultural consciousness. Therefore, it is very important to conduct in-depth research on the correlation between China’s philosophy and traditional Chinese medicine, tap the rational spirit deeply hidden in traditional Chinese medicine, provide the cultural background environment for the growth and development of traditional Chinese medicine, get rid of the dilemma of broken knowledge of traditional Chinese medicine and fight alone, and form the resultant force of cultural environment. Of course, this kind of research is not simply retro, but also to retain the essence in comparing the respective strengths of Chinese and Western cultures.

　　Juck Zhang Zhong: The Path of Philosophical Debate on the Future

　　Juck Zhang Zhong, a researcher at the China Institute of Science and Technology Information and vice-president of the Chinese Philosophy Committee of the Chinese Society for the History of Philosophy, believes that in the past century, Chinese medicine has been in a debate about its existence or abolition, and it has been in a passive position for a long time. The curative effect is the last word before a mature scientific theory gives a reasonable explanation, or before the self-explanation of Chinese medicine theory is accepted.

　　Juck Zhang said that in the process of preventing and controlling the COVID-19 epidemic, Chinese medicine once again showed the characteristics of "simplicity, convenience, experience and cheapness", which is simple and efficient. This characteristic is beyond the interpretation of modern science and civilization and is conducive to promoting a new understanding of Chinese civilization.

　　Historically, Chinese medicine not only has clinical curative effect, but also has health care function, humanistic care and life care, which embodies the cognitive style and lifestyle of the Chinese nation on a more basic level.

　　Only for a hundred years, the diversity and effectiveness of traditional Chinese medicine have been questioned by western scientific concepts, and have not been valued by Chinese people.

　　"Deeply grasping the historical responsibility of traditional Chinese medicine, deeply studying the scientific and civilized system behind the curative effect, and creating a new era interpretation system of traditional Chinese medicine integrating science and culture are major issues facing the comprehensive innovation of academic theory in China." Juck Zhang said, "Chinese medicine has always been a part of the treasure house of Chinese civilization, and it should be a new trend to distinguish between Chinese medicine and Chinese medicine." (Reporter Zhang Jianxin Bai Jiali)

　　Source: Half-monthly Talk about Internal Edition, No.5, 2020

　　Recently, the recessive infection of brucellosis (hereinafter referred to as brucellosis) in Lanzhou Veterinary Research Institute of China Academy of Agricultural Sciences has attracted attention.

　　According to CCTV news reports, as of 12: 00 on December 7th, 317 teachers and students of Lanzhou Veterinary Research Institute had been tested for Brucella, of which 96 were serologically positive and had no obvious symptoms, and were diagnosed as recessive infection. Fortunately, the probability of brucellosis transmission from person to person is extremely low, and there are no previous cases.

　　On December 9th, many doctors who have long been concerned about epidemiology accepted an interview with The Paper, saying that brucellosis patients/infected people are usually people who have been engaged in the work related to slaughtering or raising cattle and sheep for a long time, but researchers are rare, and collective infection incidents of this scale are even more rare in China. They concluded that the incident was related to the irregular operation of the laboratory.

　　How did so many people get infected with brucellosis in a short time?

　　The Paper previously reported that some students claimed that their classmates had been infected with brucellosis because of their experiments with diseased mice, and suspected that aerosol infected by germs had formed in the air.

　　In this regard, Li Qiong, vice president of the Fourth Hospital of Chaoyang City, Liaoning Province, said that pathogenic bacteria pollute the air, form aerosols in the air, and are inhaled and infected through the respiratory tract. This is indeed one of the three main ways of brucellosis transmission, and the aerosols are invisible and intangible. Even professionals can’t tell whether the air contains pathogen aerosols. The other two modes of transmission are: direct contact through skin and mucosa, such as direct contact with sick animals by shearing and milking workers in livestock farms and slaughterhouses, which leads to infection; And eating food contaminated by pathogenic bacteria leads to digestive tract infection.

　　Li Qiong said that some researchers were infected in clinical experiments, but it was the first time that nearly 100 people were found to be positive for brucellosis antibody in a short time.

　　Cai Yudong, a retired chief physician in beijing ditan hospital, has been engaged in the research of infectious diseases for 40 years. In her experience, the most common people infected with brucellosis are engaged in the work related to breeding and slaughter. Because of the long contact with animals and many links, it is difficult to prevent the source of infection. He speculated that the collective infection of teachers and students in the laboratory must have violated the operating norms.

　　Cai Yudong said that the operation specifications involved include: whether the laboratory hardware facilities are available (for example, tests involving Brucella diseases should be carried out under P3 safety protection standards), whether the human operation is standardized, and whether there is sudden accidental infection (for example, the container containing Brucella is broken to form aerosol inhalation infection).

　　Wu Hao, a professor at the Infection Center of Beijing You ‘an Hospital affiliated to Capital Medical University, also speculated that there may be loopholes in laboratory protection: "(Brucellosis infection) does not mean that adults can be infected by traveling to the countryside or eating mutton and beef, and this probability is very low. If you follow the rules, these teachers and students should not be infected. "

　　As for two serological tests, RBPT (Tiger Red Slide Agglutination Test) and SAT (Tube Agglutination Test), which some students told The Paper, were positive, Wu Hao thought that brucellosis infection could be judged by these two tests, but because some patients will also show positive results after self-healing, it should be only a preliminary screening at present. As for whether the human body has recovered or is still infected, doctors need to make further judgments based on clinical manifestations.

　　Cai Yudong also said that if the above two tests are positive at the same time, "it can basically be judged as brucellosis infection".

　　According to public information, brucellosis is a zoonotic infectious disease caused by Brucella, and it is a Class B infectious disease stipulated in the Law of People’s Republic of China (PRC) on the Prevention and Control of Infectious Diseases. The acute cases showed fever, hyperhidrosis, muscle and joint pain, fatigue and lymphadenopathy of liver and spleen. In the chronic stage, most cases show joint damage, joint stiffness, long-term fever, etc., and they can’t engage in manual labor. The masses call it the disease of paralysis and laziness. Brucellosis can also harm male testis, female ovary and other reproductive systems.

　　After the incident of brucellosis recessive infection, Lanzhou Veterinary Research Institute has successively inspected the teachers and students in the institute, and invited a team of experts to give lectures on knowledge in the school. Other institutes affiliated to China Academy of Agricultural Sciences have also successively organized physical examinations for students.

　　On December 7th, all graduate students of Lanzhou Veterinary Research Institute said that some students from Harbin Veterinary Research Institute had come to Lanzhou Veterinary Research Institute for internship this summer, and they were also found to be positive for brucellosis antibody recently after returning to Harbin. On December 9th, Heilongjiang Provincial Health and Health Commission confirmed to The Paper that imported cases of brucellosis were also found in Harbin. The staff of the Center for Disease Control of Harbin Health and Health Commission said that the Harbin Institute of Veterinary Medicine had found a hidden infection of brucellosis.

Water is the source of life, and drinking water hygiene is the basic guarantee of human health and life safety. In recent years, with the improvement of people’s living standards, the demand for healthy drinking water is changing with each passing day, and a new form of drinking water has entered thousands of households, that is, ready-made and sold water. It can be seen everywhere in residential areas, shopping malls and other places. When you choose this new water supply method, do you know what to pay attention to when buying ready-made drinking water? Is the drinking water you bought up to standard? Let the health supervisor answer your questions one by one:

1. What is ready-made and ready-to-sell drinking water?

Ready-made and ready-to-sell drinking water refers to the water supply mode that municipal tap water is used as the water source, and drinking water is produced on site through water quality treatment equipment and sold directly in bulk.

Second, how to hold the ready-made drinking water?

Consumers should use food-grade clean buckets, bottles and other containers that can hold food to hold ready-made drinking water.

3. Can the existing drinking water be drunk raw?

The existing drinking water does not have the necessary conditions for long-term storage, so after buying it back, it should be used in the shortest possible time to prevent deterioration, and it should not be left for too long. At the same time, consumers are advised to drink it after boiling, and it is not appropriate to drink it directly.

4. What should we pay attention to when buying ready-made water for sale?

1. Look at the environment: it depends on the sanitary conditions around the water-selling equipment and whether there are pollution sources;

2. Look at the information publicity column of drinking water equipment: whether the relevant information is publicized in a conspicuous position as required;

3. Look at the condition of the water vending machine: Look at whether the water vending machine is operating normally and whether the safety protection door is damaged.

5. What conditions should the existing drinking water equipment meet?

The water quality processor used for on-site production of drinking water (including the automatic drinking water vending machine) must:

1. Obtain the approval of hygiene license for water-related products;

2. Municipal tap water is used as raw water;

3. The effluent quality meets the requirements identified by the water quality processor;

4, its appearance should be clean, no rust or damage;

5, the outlet must have a concave isolation area, to avoid pollution, the outlet should also be installed with a tightly closed door that can automatically close, and when the water is not sold, the door should be closed;

6. The propaganda words on the equipment shall meet the requirements of the Management Specification for Labeling Instructions of Waterrelated Products.

Sixth, how to deal with water quality problems?

When the existing drinking water has peculiar smell, peculiar smell or something visible to the naked eye, consumers should immediately stop using it, and immediately inform the existing drinking water business units according to the information of the business units publicized on the equipment, and ask them to dispose of it in time. If necessary, it can be reported to the local health supervision department (Tianxin District can call 85899720 for on-site inspection by Tianxin District health supervision department).

Special reminder:

The existing drinking water is filtered and absorbed by water treatment technology to improve the water quality, but it does not have any function of treating diseases or health care. Business units shall not imply or express that the water sold now is "spring water", which is used for medical purposes, improves health performance or has curative effect. The contents such as acidic water, alkaline water, activated water, small molecular water, functional water, energy water and oxygen-rich water shall not be marked.

Original title: "Drinking Water Publicity Week" Do you know about drinking water now? 》

Read the original text

　　In order to effectively protect the health of the broad masses of people in Dalian and implement various measures for epidemic prevention and control in Dalian, the COVID-19 Epidemic Prevention and Control Headquarters is scheduled to conduct regional nucleic acid screening for permanent population, temporary population and floating population in some districts and counties of Dalian (Jinpu New District, Pulandian District, wafangdian city, zhuanghe city, Changxing Island Economic Zone and Changhai County) from 6:00 to 22:00 on April 13th. The relevant matters are hereby notified as follows:

　　The general public are requested to go to the nucleic acid sampling point in batches, at the wrong time and in an orderly manner under the arrangement of local streets (towns) and communities (villages) in accordance with the requirements of "every person should be inspected" and complete the sampling work according to the guidance of the staff. Wear a mask correctly during the sampling process, do not talk to others and keep a social distance of more than 1 meter, pay attention to weather changes and travel safety.

　　When sampling nucleic acid, please ask the general public to take the initiative to show the "Liaoshitong Health Code". Old people or children who don’t or can’t use smart phones, please ask their families and neighbors to show their codes on their behalf, or bring their ID cards (those without ID cards bring their household registration books).

　　While waiting for the results of nucleic acid screening, please ask the general public to consciously abide by the requirements of Dalian’s current epidemic prevention and control, minimize social activities and reduce personnel gathering. Those who refuse to cooperate with this round of regional nucleic acid screening without justifiable reasons will bear corresponding legal responsibilities.

　　CCTV News:On September 9th, the Consumer Protection Bureau of China Banking and Insurance Regulatory Commission, China issued the Circular on Consumer Complaints in the Banking Industry in the Second Quarter of 2021.

　　According to the Circular, in the second quarter of 2021, China Banking and Insurance Regulatory Commission and its agencies received and forwarded 84,424 consumer complaints from the banking industry, an increase of 25.5% compared with the second quarter of 2020. Among them, 26,537 large state-owned commercial banks were involved, up 12.9% year-on-year, accounting for 31.4% of the total complaints; There were 35,135 joint-stock commercial banks, up 22.4% year-on-year, accounting for 41.6% of the total complaints; There were 367 foreign-funded corporate banks, a year-on-year decrease of 1.6%, accounting for 0.4% of the total complaints; 8928 city commercial banks (including private banks), up 53.8% year-on-year, accounting for 10.6% of the total complaints; There were 5037 small and medium-sized financial institutions in rural areas, up 94.0% year-on-year, accounting for 6.0% of the total complaints; There were 8,420 other banking financial institutions, with a year-on-year increase of 34.4%, accounting for 10.0% of the total complaints.

　　According to the Circular, among the large state-owned commercial banks, the complaints of Agricultural Bank and Industrial and Commercial Bank rank in the top two. Among the joint-stock commercial banks, China Everbright Bank and China CITIC Bank ranked the top two in terms of complaints. Among foreign-funded corporate banks, Bank of East Asia ranks first in the number of complaints.

　　The Circular also shows that the median number of complaints per 10 million individual customers of large state-owned commercial banks is 73.6. The median number of complaints per 10 million individual customers of joint-stock commercial banks is 338.0. The median number of complaints per 10 million individual customers of foreign-funded corporate banks is 358.4.

　　Judging from the business involved in the complaint, the second quarter of 2021 involvedThere were 46,273 complaints about credit card business, with a year-on-year increase of 37.2%, accounting for 54.8% of the total complaints.. Bank of Communications and Agricultural Bank of China rank among the top two large state-owned commercial banks in terms of complaints about credit card business. China Everbright Bank, China CITIC Bank and Minsheng Bank rank among the top three joint-stock commercial banks in terms of credit card complaints. The number of complaints about credit card business of Bank of East Asia ranks first among foreign-funded corporate banks.

　　The Bulletin shows that:

　　In the second quarter of 2021,There were 23,059 complaints about personal loan business, with a year-on-year increase of 52.2%., accounting for 27.3% of the total complaints. Industrial and Commercial Bank of China (ICBC) and Agricultural Bank of China (ABC) are among the top two large state-owned commercial banks in terms of personal loan complaints. Everbright Bank and Ping An Bank are among the top two joint-stock commercial banks in terms of personal loan complaints. The number of complaints about personal loan business of Standard Chartered Bank ranks first among foreign-funded corporate banks.

　　In the second quarter of 2021, there were 4,334 complaints about wealth management business, a year-on-year decrease of 59.2%, accounting for 5.1% of the total complaints. The number of complaints about wealth management business of Postal Savings Bank ranks first among large state-owned commercial banks. China Merchants Bank, China Everbright Bank and Ping An Bank rank among the top three joint-stock commercial banks in terms of complaints about wealth management business.

Vaccination combined with effective personal protection is still the most effective means to prevent Covid-19. Recently, many districts in Beijing have announced the latest vaccination spots and service hours in COVID-19. Please collect and forward them to citizens in need. At the same time of personal protection, residents should be vaccinated with COVID-19 vaccine as soon as possible to contribute to epidemic prevention and control.

Xicheng District

From March 3, 2023, the latest vaccination point information in Xicheng District:

Morning inoculation time: 8:30-11:00.

Inoculation time in the afternoon: 13:30-16:00.

(except holidays)

Dongcheng District

From March 1st, 15 health departments in Dongcheng District can be vaccinated with COVID-19 vaccine. Welcome people who are willing to vaccinate and meet the requirements, and complete the vaccination according to the time announced by each health department.

Morning inoculation time: 8:30-11:00.

Inoculation time in the afternoon: 13:30-16:00.

Chaoyang District

Open vaccination sites every day.

Friends who haven’t been vaccinated can search for "Shengzhi Health" through WeChat applet or Alipay, and choose the inoculation point in Chaoyang District to make an appointment. After the appointment is successful, they can take their ID card to vaccinate. Older people who are inconvenient to use smart phones don’t have to worry. They can go to the site to consult the staff and take the green channel for vaccination.

In addition, at present, Chaoyang District can make an appointment to inoculate inhaled recombinant Covid-19 vaccine (adenovirus type 5) for free. The latest list of inoculation points of inhaled vaccine in Chaoyang District is as follows, and residents who need vaccination are invited to vaccinate. (Note: The specific vaccination information is based on the actual situation. Residents who need vaccination suggest that you consult in advance. )

Inhalation vaccination site

Tongzhou district

Information publicity of vaccination sites in COVID-19

(From February 15th, 2023)

Fangshan district

Huairou district

From March 1 ST

Vaccination sites in COVID-19

Settings and service hours have changed.

longshan subdistrict

Name of inoculation point: Longshan Street Community Health Service Center

Address: No.24, South Street, Longshan Street

Vaccination population: over 3 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 61628130/18910763181

Service time: Friday and Saturday (8:30-11:00), and make an appointment to enter the community/village for vaccination on Friday.

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Quanhe neighborhood

Name of inoculation point: Floor 3, Outpatient Building, Quanhe Street Community Health Service Center

Address: No.15, Xiaozhong Fule District 2, Quanhe Street

Vaccination population: over 3 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine, Anhui Zhifei recombination vaccines (CHO cells), Zhuhai Livzon recombination vaccines (CHO cells) and Beijing Wan Tai nasal spray vaccine.

Tel: working day: 69631472/69659022, other time: 69685145.

Service time: Monday and Sunday (8:30-11:00), and make an appointment to enter the community/village for vaccination on Friday.

Vaccination appointment method at inoculation point: Anhui Zhifei recombination vaccines (CHO cell), Beijing Wan Tai nasal spray vaccine, Zhuhai Livzon recombination vaccines (CHO cell) need to make an appointment on site or by telephone, and other vaccinations do not need to make an appointment.

Yanqi town

Name of inoculation point: Department of Prevention and Protection, Yanqi Hospital

Address: No.434, Xiazhuang Village, Yanqi Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine, Anhui Zhifei recombination vaccines (CHO cells), recombination vaccines for Kangxinuo injection (adenovirus type 5 vector), recombination vaccines for Kangxinuo inhalation (adenovirus type 5 vector) and Beijing Wan Tai nasal spray vaccine.

Tel: 18518328628

Service time: Thursday and Friday (14:00-16:00) and Thursday (9:00-11:00) are reserved for community/village inoculation (note: only recombination vaccines (CHO cell) of Anhui Zhifei, recombination vaccines for injection of Kangxinuo (adenovirus type 5) and recombination vaccines (adenovirus type 5) for inhalation of Kangxinuo are provided on Thursday afternoon.

Vaccination appointment methods at inoculation sites: Anhui Zhifei recombination vaccines (CHO cells), recombination vaccines for Kangxinuo injection (adenovirus type 5 vector), recombination vaccines for Kangxinuo inhalation (adenovirus type 5 vector) and Beijing Wan Tai nasal spray vaccine require on-site appointment or telephone appointment, and other vaccines do not require appointment.

Huairou town

Name of inoculation point: Huairou Town Community Health Service Center

Address: No.1 Houheng Street, Huairou District

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine, recombination vaccines for Kangxinuo injection (adenovirus type 5 vector), recombination vaccines for Kangxinuo inhalation (adenovirus type 5 vector) and Beijing Wan Tai nasal spray vaccine.

Tel: 69698120 89691301

Service hours: Wednesday and Friday (8: 30-10: 30); Make an appointment to enter the community/village for vaccination on Friday.

(Note: recombination vaccines (adenovirus type 5 vector) for injection of Beijing Kexing Zhongwei, Beijing Bio and Kangxinuo, and Wan Tai nasal spray vaccination service will be provided on Friday; Only recombination vaccines (adenovirus type 5 vector) inoculation service for Kangxinuo inhalation is provided on Wednesday).

Vaccination appointment method at inoculation point: recombination vaccines for Kangxinuo injection (adenovirus type 5 vector), recombination vaccines for Kangxinuo inhalation (adenovirus type 5 vector) and Beijing Wan Tai nasal spray vaccine need to be made on-site or by telephone, and other vaccinations do not need to be made in advance.

Miaocheng town

Name of inoculation point: Miaocheng Town Cultural Center

Address: about 50 meters north of the west gate of Xinxin Town.

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 60694154

Service time: Tuesdays and Thursdays (15:00-17:00), and appointments are made for vaccination in the village on Wednesdays and Fridays.

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Qiaozi town

Name of inoculation point: Qiaozi Town Community Health Service Center

Address: Chawu Railway Area, Qiaozi Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine, recombination vaccines for Kangxinuo inhalation (adenovirus type 5 vector) and Beijing Wan Tai nasal spray vaccine.

Tel: 60636802/69676542

Service time: Monday, Wednesday and Friday (9:00-11:00), and appointment for vaccination in the village on Tuesday, Thursday, Saturday and Sunday (Note: recombination vaccines (adenovirus type 5 vector) for Kangxinuo inhalation and Wan Tai nasal spray vaccination service can be provided on Wednesday morning).

Vaccination appointment method at inoculation point: recombination vaccines (adenovirus type 5) and Wan Tai nasal spray vaccine for Kangxinuo inhalation need to be made on-site or by telephone, and other vaccinations do not need to be made.

Beifang town

Name of Inoculation Site: Multifunctional Hall of Prime Minister Village, Beifang Town

Address: the front yard of Xiangxiazhuang Village Committee, Beifang Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 61681701

Service time: Wednesday, Friday, Sunday (9:00-11:00), Monday, Tuesday, Thursday and Saturday (9: 00-11: 00) to make an appointment for vaccination in the village (note: Wan Tai nasal spray vaccination service can be provided on Friday morning).

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Yangsong town

Name of inoculation point: No.11 Fengxiang Street, Yangsong Town

Address: No.11 Fengxiang Street, Yangsong Town (intersection on the west side of enterprise centralized office area in Yangsong Town)

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 61675894/61678426/61678405/61678402

Service time: Tuesday and Saturday (14:00-16:00), and Friday (9: 00-11: 00) to make an appointment for vaccination in the village (note: Wan Tai nasal spray vaccination service can only be provided on Saturday afternoon).

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Huaibei town

Name of inoculation point: Huaibei Town Community Health Service Center

Address: No.312, Xizhuang Village, Huaibei Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 69663186/18611063080

Service time: make an appointment to enter the village for vaccination on Monday, Wednesday, Friday (9:00-11:00), Tuesday and Saturday (9:00-11:00) (Note: Wan Tai nasal spray vaccination service can be provided on Wednesday morning).

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Bohai town

Name of inoculation point: Bohai Town Community Health Service Center

Address: West of Bohai Suocun Village, Bohai Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 18910766356

Service time: make an appointment to enter the village for vaccination on Monday and Thursday (9:00-11:00), Wednesday, Friday and Saturday.

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Jiuduhe town

Name of inoculation point: Jiuduhe Town Community Health Service Center

Address: No.217 Huanghuacheng Village, Jiuduhe Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 61651184

Service hours: Tuesday (9:00-11:00), Thursday (13:30-15:30), Monday, Wednesday, Friday, Saturday and Sunday.

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Liulimiao town

Name of inoculation point: Liulimiao Town Community Health Service Center

Address: No.17 Liulimiao Village, Liulimiao Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 61610541

Service time: Monday and Wednesday (9:00-10:30), and Friday (9:00-10:00) to make an appointment for vaccination in the village.

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Tanghekou town

Name of inoculation point: Tanghekou Town Community Health Service Center

Address: No.55 Tanghekou Street, Tanghekou Town

Vaccination population: over 3 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine, recombination vaccines for Kangxinuo injection (adenovirus type 5 vector) and Beijing Wan Tai nasal spray vaccine.

Tel: 89671020

Service time: Thursday (14:00-16:00), Saturday (9:00-11:00), and appointment for vaccination in the village on Tuesday (Note: vaccination service can be provided for people aged 3-17 on Saturday morning; Recombination vaccines (adenovirus type 5) inoculation service for Kangxinuo injection can be provided on Thursday afternoon).

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine and recombination vaccines (adenovirus type 5) for Kangxinuo injection need to be made on-site or by telephone, and other vaccinations do not need to be made in advance.

the town of baoshan

Name of inoculation point: Baoshan Town Community Health Service Center

Address: Baoshan Temple Village, Baoshan Town

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 61689012

Service time: Monday, Wednesday and Friday (9:00-11:00), Tuesday, Thursday, Saturday and Sunday (9:00-11:00) to make an appointment for vaccination.

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Changshaoying town

Name of inoculation point: Changshaoying Manchu Township Community Health Service Center

Address: Shaoying Village, Changshaoying Township Head

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine, recombination vaccines for Kangxinuo inhalation (adenovirus type 5 vector) and Beijing Wan Tai nasal spray vaccine.

Tel: 60621807/60621945

Service time: Monday (9:00-11:00), Tuesday (13:30-15:30), Wednesday, Thursday, Friday, Saturday and Sunday (9:00-11:00). (Note: recombination vaccines (adenovirus type 5) for Kangxinuo inhalation can be inoculated on Tuesday afternoon.

Vaccination appointment method at inoculation point: recombination vaccines (adenovirus type 5) and Wan Tai nasal spray vaccine for Kangxinuo inhalation need to be made on-site or by telephone, and other vaccinations do not need to be made.

Labagoumen town

Name of inoculation point: Labagoumen Manchu Township Community Health Service Center

Address: 50 meters west of Labagoumen Manchu Township People’s Government.

Vaccination population: over 18 years old

Vaccination types: Beijing Kexing Zhongwei vaccine, Beijing biological vaccine and Beijing Wan Tai nasal spray vaccine.

Tel: 13581996916

Service time: Monday (13:30-15:00), Tuesday, Wednesday, Thursday and Friday (9:00-11:00), Saturday and Sunday (9:00-10:00), make an appointment for vaccination in the village (note: Wan Tai nasal spray vaccination service can be provided on Tuesday morning).

Vaccination appointment method at inoculation point: Wan Tai nasal spray vaccine needs on-site appointment or telephone appointment, and other vaccinations don’t need appointment.

Economic development zone

Changping district

(Beijing Daily client)

　　CCTV News:According to "Xiangtan CDC" WeChat WeChat official account news, on October 10th, 2022, a case of asymptomatic COVID-19 infection was found in Xiangtan County, Hunan Province during the quarantine control of key personnel involved in the epidemic, and is currently being isolated and observed in designated hospitals. Xiangtan City and Xiangtan County have immediately launched emergency response, and fully carried out the work of tracing the source, investigation and control, nucleic acid detection and on-site disposal.

　　Main activity track:

　　October 5 th

　　At 10:30, drive from Shangshuyuan, Ganlong, Yisuhe Town, Xiangtan County to Shengshi Kangcheng.

　　Drive to Haitang Garden at 11:00.

　　Drive from Haitang Garden to Changsha at 11:30.

　　13:10 Arrive at the ground parking lot of New Times Square in Kaifu District, Changsha City.

　　Attend the training from 13: 20 to 18: 00 on the 10th floor of North Building of New Times Square.

　　From 18: 00 to 21: 00, have dinner at the Lotus Pond Restaurant opposite New Times Square.

　　At 21:00, I drove back to Xiangtan from Outangbian Restaurant.

　　At 22:30, it passes through the second phase of Napaxigu Community in Yuetang District, Xiangtan City.

　　22:42-23:31 Arrive near Hongsheng Yipin Mansion in Yuetang District and chat on the private car.

　　At 24:00, I passed the Haitang Garden in Yisuhe Town and returned to the home of Shangshuyuan in Ganlong, and did not go out after that.

　　October 6th.

　　At 9:45, I drove from Ganlong Shangshuyuan to the famous teacher’s shop to shampoo.

　　At 10:25, I started from a famous teacher’s shop and stopped at the roadside of Forest Yayuan Community on Dapeng Road for a short time.

　　10:30-11:17 Decoration design in Shengshi Kangcheng.

　　Arrive at Haitang Garden by car at 11:26.

　　At 12:02, I drove from Haitang Garden to Changsha.

　　13:30 Arrive at the ground parking lot of New Times Square in Kaifu District, Changsha City.

　　Attend the training from 13: 30 to 18: 00 on the 10th floor of North Building of New Times Square.

　　18:10-21:00, eat at the Lotus Pond Restaurant opposite New Times Square.

　　At 21:00, take a private car (on behalf of the peers) and leave from the restaurant at Outangbian and return.

　　At 22:00, it passes through the second phase of Napaxigu Community in Yuetang District, Xiangtan City.

　　Arrive at Xiangtan Maternal and Child Health Hospital at 22:15 and stay for about 2 minutes.

　　22:35-23:15 Drive back to Haitang Garden and chat in the car.

　　At 23:24, I drove back to my home in Shangshuyuan, Qianlong, and didn’t go out after that.

　　October 7th.

　　From 11: 50 to 13: 25, drive from Shangshuyuan in Qianlong to attend the wedding in the Lotus Hall on the first floor of Xintian International Hotel.

　　13:46-14:18 Drive to Lianhai Trade City to buy decoration materials.

　　At 14:35, I drove back to my home in Shangshuyuan, Qianlong.

　　21:00-21:04 Drive to Haitang Garden.

　　At 23:10, the self-driving car arrived at the charging station of Jiangwan Square to charge the car.　

　　October 8 th

　　At 1:00, drive back to Ganlong Shangshuyuan from Jiangwan Square charging station.

　　At 15:22, I drove to Xiangtan County People’s Hospital to carry out nucleic acid detection, and then transferred it to a designated hospital for isolation observation. Since October 5, people who have crossed the above activity tracks immediately took the initiative to report to their communities (villages), work units or hotels, and cooperated with the implementation of corresponding prevention and control measures such as centralized isolation, nucleic acid detection and health monitoring. The general public and those who come to (return to) Tan are requested to pay attention to the official authority release, and do not believe in rumors, spread rumors or make rumors; Enhance awareness of prevention, strictly implement the requirements of "health first responsible person", take the initiative to fulfill epidemic prevention obligations, pay attention to their own health status, do personal protection, maintain a safe social distance, and contribute to epidemic prevention and control. Those who do not cooperate with the implementation of prevention and control measures and cause the spread of the epidemic will be investigated for legal responsibility according to law.

　　Now, the candidates and projects recommended by the evaluation committee for the highest science and technology award, natural science award, technological invention award, scientific and technological progress award and international science and technology cooperation award in Shandong Province in 2015 will be publicized to the public.
　　The candidates and projects for publicity were also publicized on the websites of Shandong Provincial People’s Government (http://www.shandong.gov.cn), Shandong Provincial Department of Science and Technology (http://www.sdstc.gov.cn) and Science and Technology Information on November 6, 2015.
　　According to the relevant regulations, if there is any objection to the proposed award candidates and projects publicized, it shall be submitted in writing within 30 days from the date of publicity to the office of Shandong Science and Technology Awards Committee (located in the Science and Technology Achievements Department of the Provincial Science and Technology Department, address: No.607 Shunhua Road, Jinan High-tech Zone, zip code: 250101).

　　Shandong Province Science and Technology Highest Award (2 persons)
Li Shucai
　　Li Shucai, male, born in December 1965, Laishui, Hebei Province, graduated from Shandong University of Science and Technology in 1987. In 1990, he received a master’s degree in geotechnical engineering from Shandong University of Science and Technology, and a doctoral degree in geotechnical engineering from Wuhan Institute of Geotechnical Mechanics, Chinese Academy of Sciences in 1996. He is currently the vice president, professor and doctoral supervisor of Shandong University. In 2006, he was supported by the National Fund for Distinguished Young Scholars, and in 2007, he was selected as a Changjiang Scholar distinguished professor. He has served as deputy director of the Key Laboratory of Geotechnical Mechanics of Chinese Academy of Sciences and vice president and dean of the School of Civil Engineering and Water Conservancy of Shandong University. He is also the vice chairman of the Chinese Society of Rock Mechanics and Engineering and the chairman of the Underground Engineering Branch of the Chinese Society of Rock Mechanics and Engineering. He is the chief scientist of the National 973 Program, the first batch of "Ten Thousand Talents Program" and the national outstanding scientific and technological workers.
　　Professor Li Shucai has been engaged in the research and development of geotechnical engineering for 25 years, and closely combined with the major needs of disaster prevention and mitigation of water inrush and mud outburst in infrastructure construction such as highways and railways, he has created key technologies such as advanced prediction of tunnel adverse geology, prediction, early warning and treatment of water inrush and mud outburst, which has made outstanding contributions to disaster prevention and mitigation in tunnel construction.
　　The theory, method and technology of advanced prediction of unfavorable geology such as tunnel water inrush and mud outburst disaster source were established, and the method and instrument for estimating the water content in front of the tunnel were invented, which realized the three-dimensional imaging of the disaster-causing structure and the estimation of static water storage in the range of about 40m in front of the tunnel. It was successfully applied to the tunnel construction by drilling and blasting method for more than 100 times, and was first carried on the TBM produced by our country. A four-stage comprehensive advanced prediction method and technology are established, which greatly improves the prediction accuracy. It solves the key problems of "undetectable, inaccurate and quantitative" in disaster source prediction.
　　The comprehensive prediction theory and early warning key technology of major water inrush and mud outburst disasters in tunnels are established, and the effective prevention and active regulation of dynamic disasters of water inrush and mud outburst are realized. The method and technology of water inrush and mud outburst disaster control are innovated, and the technical problem of high pressure and large flow dynamic water plugging is solved.
　　The achievements have been successfully applied in a series of national key and difficult projects, such as the high-risk karst tunnel group of Hubei Hurongxi Expressway, Qingdao Jiaozhou Bay subsea tunnel, Chenglan railway tunnel group, Three Gorges dam-turning expressway tunnel group, Hubei West Expressway tunnel group, Jiangxi Jilian Expressway Yonglian Tunnel, Nanjing Metro, Guangzhou Metro and Qingdao Metro, which have avoided the occurrence of major water inrush and mud outburst disasters and ensured the safety construction of the project.
　　Professor Li Shucai presided over more than 20 national science and technology projects, and enterprises and institutions entrusted more than 100 major projects. He won four second prizes for national scientific and technological progress (two first prizes, one second prize and one fourth prize respectively), four first prizes for provincial and ministerial scientific and technological progress (all first prizes), published more than 120 papers included in SCI/EI, published four monographs and authorized 25 invention patents (all first prizes). More than 50 doctoral and master students have been trained.
Chen Zijiang
　　Chen Zijiang, female, born in October 1959, Liuyang, Hunan, is a professor and doctoral supervisor of Shandong University. Graduated from Shandong Medical College in 1984 with a bachelor’s degree in medicine; In 1986, he obtained a master’s degree in obstetrics and gynecology from Shandong Medical College. In 1989, he received a doctoral degree in obstetrics and gynecology from Shandong Medical College. He is currently vice president of Shandong University, director of Qilu Medical Department, director of reproductive medicine research center, director of key laboratory of reproductive endocrinology and Ministry of Education, and director of national assisted reproduction and eugenics engineering technology research center. He is a famous obstetrician and gynecologist, the chief scientist of the National 973 Program, a leading figure in gynecology and endocrinology in China, and a winner of the National "May 1" Labor Medal and the the State Council Municipal Government Allowance. He is currently a core member of several important international academic organizations and enjoys a high international reputation.
　　It has established the only "National Research Center for Assisted Reproductive and Eugenics Engineering Technology" in the field of reproductive medicine in China, pioneered human intrauterine gamete transplantation (GIUT) and ultrasound minimally invasive treatment of polycystic ovary syndrome (PCOS), and successively gave birth to the world’s first GIUT IVF and China’s first IVF IVF IVF. The success rate of its leading team’s assisted reproductive technology (ART) is 55%, which is at the world’s leading level. Through the close combination of assisted reproductive technology and the prevention and treatment of genetic diseases, we have independently developed and applied the preimplantation genetic diagnosis technology covering more than 100 genetic diseases, giving birth to the first healthy offspring of genetic carriers such as hereditary deafness and hepatolenticular degeneration in China, helping more than 1,000 families with a history of genetic diseases to have healthy children every year, making an important contribution to improving the quality of the population.
　　The study of genetic etiology of PCOS has solved the world problem. In-depth study of the etiology and pathology of PCOS and other diseases has found and identified a number of new genes related to the disease, providing new targets for early prevention and treatment of the disease. The results have been published in internationally renowned magazines such as Nature Genetics and American Human Genetics. Professor Strauss, a famous American gynecologist and academician, called it a "major milestone" in the history of PCOS genetics research.
　　Professor Chen Zijiang presided over 3 major national scientific research projects (973 projects), 1 "863" project, 1 special scientific research project of public health industry and 1 key project of National Natural Science Foundation. Won two second prizes for national scientific and technological progress (first and second respectively), one third prize for national invention (second place), one science and technology prize in ho leung ho lee foundation (first place) and one second prize in China Medical Science and Technology Award (first place); Won two first prizes for scientific and technological progress in Shandong Province (both first). Has trained more than 100 doctors, masters and 12 postdoctoral students; There is one excellent blogger in China and three outstanding talents in the new century from the Ministry of Education.
Shandong Natural Science Award
First prize (5 items)
　　1. Research on the theory and application of fractional calculus in abnormal transport process.
　　Completed by: Jiang Xiaoyun (Shandong University)
　　　　　　Wang Shaowei (Shandong University)
　　　　　　Qi Haitao (Shandong University)
　　　　　　Cui Mingrong (Shandong University)
　　2. Fluorescence sensing analysis of intracellular active molecules related to major diseases.
　　Completed by: Tang Bo (Shandong Normal University)
　　　　　　Li Ping (Shandong Normal University)
　　　　　　Li Na (Shandong Normal University)
　　　　　　Wang Xu (Shandong Normal University)
　　3. Basic research and sensing mechanism of paper chip microfluidic based on structural control and photoelectric properties.
　　Completed by: Yu Jinghua (Jinan University)
　　　　　　Ge Shenguang (Jinan University)
　　　　　　Yan Mei (Jinan University)
　　　　　　Huang Jiadong (Jinan University)
　　4. The new discovery and functional study of leprosy dermatosis gene.
　　Completed by: Zhang Furen (Shandong Institute of Dermatology and STD Prevention)
　　Liuhong (Shandong Institute of Dermatology and STD Prevention)
　　Fu Xi ‘an (Shandong Institute of Dermatology and STD Prevention)
　　Wang Chuan (Shandong Institute of Dermatology and STD Prevention)
　　Yang Qing (Shandong Institute of Dermatology and STD Prevention)
　　5. Study on the mining and regulation mechanism of plants’ genes responding to temperature and high salt stress.
　　Completed by Zheng Chengchao (Shandong Agricultural University)
　　　　　　Wu Chang ‘ai (Shandong Agricultural University)
　　　　　　Huang Jinguang (Shandong Agricultural University)
　　　　　　Yan Kang (Shandong Agricultural University)
　　　　　　Yang Guodong (Shandong Agricultural University)
Second prize (9 items)
　　1. Numerical methods of convection-diffusion equation and Stokes-Darcy coupling equation.
　　Completed by: Rui Hongxing (Shandong University)
　　　　　　Wang Kaixin (Shandong University)
　　　　　　Fu Hongfei (Shandong University)
　　　　　　Zhang Ran (Shandong University)
　　2. Dissipation, stability and control of stochastic nonlinear systems.
　　Completed by: Wu Zhaojing (Yantai University)
　　　　　　Cui Mingyue (Qufu Normal University)
　　3. Research on the application of quantum entanglement in quantum information and dynamic manipulation.
　　Completed by: Xia Yunjie (Qufu Normal University)
　　　　　　Man Zhongxiao (Qufu Normal University)
　　　　　　Zhang Yingjie (Qufu Normal University)
　　4. Study on surface wetting bionics and surface/interface mechanics of micro-nano structures.
　　Completed by: Liu Jianlin (China Shiyou University (East China))
　　　　　　Xiare (Wuhan University)
　　5. Structural characteristics and quantum scattering of small molecules
　　Completed by: Zheng Yujun (Shandong University)
　　　　　　Han Boran (Shandong University)
　　　　　　Ding Shiliang (Shandong University)
　　6. Study on the influence of material microstructure and electronic structure regulation on its physical properties.
　　Completed by: Huang Baibiao (Shandong University)
　　　　　　Dai Ying (Shandong University)
　　　　　　Wang Zeyan (Shandong University)
　　　　　　Zheng Zhaoke (Shandong University)
　　　　　　Cheng Hefeng (Shandong University)
　　7. A series of studies on the pathogenesis of immune thrombocytopenia.
　　Completed by: Hou Ming (Qilu Hospital of Shandong University)
　　　　　　Shi Yan (Qilu Hospital of Shandong University)
　　　　　　Peng Jun (Qilu Hospital of Shandong University)
　　　　　　Wang Lin (Qilu Hospital of Shandong University)
　　　　　　Liu Xinguang (Qilu Hospital of Shandong University)
　　8. Microbial monitoring in aquaculture environment and its infection effect and the occurrence, spread and infection mechanism of aerosol.
　　Completed by: Chai Tongjie (Shandong Agricultural University)
　　　　　　Wang Yaling (Shandong Agricultural University)
　　　　　　Li Xiaoxia (Shandong Agricultural University)
　　　　　　Duan Huiyong (Shandong Agricultural University)
　　　　　　Zhong Zhaobing (Shandong Agricultural University)
　　9. Diversity of Genus and Species of Asexual Myxomycetes
　　Completed by: Zhang Xiuguo (Shandong Agricultural University)
　　　　　　Ma Jian (Shandong Agricultural University)
　　　　　　Zhang Yidong (Shandong Agricultural University)
　　　　　　Zhang Kai (Shandong Agricultural University)
　　　　　　Ma Liguo (Shandong Agricultural University)
Shandong Technological Invention Award
First prize (4 items)
　　1. Multi-character compound breeding technology for various aquatic animals.
　　Completed by:
　　Kong Jie (Huanghai Fisheries Research Institute, Chinese Academy of Fishery Sciences)
　　Luan Sheng (Huanghai Fisheries Research Institute, Chinese Academy of Fishery Sciences)
　　Meng Xianhong (Huanghai Fisheries Research Institute, Chinese Academy of Fishery Sciences)
　　Wang Weiji (Huanghai Fisheries Research Institute, Chinese Academy of Fishery Sciences)
　　Luo Kun (Huanghai Fisheries Research Institute, Chinese Academy of Fishery Sciences)
　　Wang Qingyin (Huanghai Fisheries Research Institute, Chinese Academy of Fishery Sciences)
　　2. Key technologies and applications of heat-proof, wave-transparent and load-bearing integrated multifunctional materials.
　　Completed by:
　　Wang Chonghai (Sinoma High-tech Materials Co., Ltd.)
　　Wang Hongsheng (Sinoma High-tech Materials Co., Ltd.)
　　Wei Qihong (Sinoma High-tech Materials Co., Ltd.)
　　Li Ling (Sinoma High-tech Materials Co., Ltd.)
　　Liao Rong (Sinoma High-tech Materials Co., Ltd.)
　　Di Ping (Shandong Industrial Ceramics Research and Design Institute Co., Ltd.)
　　3. Analysis method and key control technology of deformation and failure of nonholonomic rock mass under complex conditions.
　　Completed by: Jiang Yujing (Shandong University of Science and Technology)
　　Wang Gang (Shandong University of Science and Technology)
　　Wang Qi (Shandong University)
　　Zhang Bo (Shandong University)
　　Li Fangdong (China Railway 14th Bureau Group Fifth Engineering Co., Ltd.)
　　Wu Xuezhen (Shandong University of Science and Technology)
　　4. Rapid pyrolysis of agricultural and forestry wastes in self-mixing downward circulating fluidized bed and high-value cascade utilization of products.
　　Completed by: Tian Yuanyu (Shandong University of Science and Technology)
　　Qiao Yingyun (Shandong University of Science and Technology)
　　Gaixikun (Shandong University of Science and Technology)
　　Qiao sheng (Beijing news technology co., ltd.)
　　Sun Mingguang (Shandong Innovation Humic Acid Technology Co., Ltd.)
　　Feng Guangxiang (Beijing Aojia Ecological Agriculture Co., Ltd.)
Second prize (7 items)
　　1. Development and application of small and medium-sized energy-saving refrigeration equipment and high-humidity frost-free cold storage.
　　Completed by: Rumeson (shandong institute of pomology)
　　　　　　Wang Shuzhen (shandong institute of pomology)
　　　　　　Yang Juanxia (shandong institute of pomology)
　　　　　　Yulanling (shandong institute of pomology)
　　　　　　Zhang Xuedan (shandong institute of pomology)
　　　　　　Sun Jiazheng (shandong institute of pomology)
　　2. Green preparation, separation and purification technology of chitosan oligosaccharide and oligosaccharide and its application.
　　Completed by: Li Pengcheng (Institute of Oceanography, China Academy of Sciences)
　　　　　　Xing Ronge (Institute of Oceanography, China Academy of Sciences)
　　　　　　Liu Song (Institute of Oceanography, China Academy of Sciences)
　　　　　　Li Kecheng (Institute of Oceanography, China Academy of Sciences)
　　　　　　Qin Yukun (Institute of Oceanography, China Academy of Sciences)
　　　　　　Yu Huahua (Institute of Oceanography, China Academy of Sciences)
　　3. Key technologies of mass storage system
　　Completed by:
　　Wang Endong (Inspur Electronic Information Industry Co., Ltd.)
　　Zhang Haitao (Inspur Electronic Information Industry Co., Ltd.)
　　Wenzhongling (Inspur Electronic Information Industry Co., Ltd.)
　　Li Ruidong (Inspur Electronic Information Industry Co., Ltd.)
　　Zhang Liqiang (Inspur Electronic Information Industry Co., Ltd.)
　　Ge Feng (Inspur Electronic Information Industry Co., Ltd.)
　　4. Development of MRC geo-steering system.
　　Completed by:
　　Yang Jinzhou (Drilling Technology Research Institute of Sinopec Shengli Petroleum Engineering Co., Ltd.)
　　Zhang Haihua (Drilling Technology Research Institute of Sinopec Shengli Petroleum Engineering Co., Ltd.)
　　Yang Quanjin (Drilling Technology Research Institute of Sinopec Shengli Petroleum Engineering Co., Ltd.)
　　Li Shan (Drilling Technology Research Institute of Sinopec Shengli Petroleum Engineering Co., Ltd.)
　　Xiao Hongbing (Drilling Technology Research Institute of Sinopec Shengli Petroleum Engineering Co., Ltd.)
　　Qinglong Liu (Drilling Technology Research Institute of Sinopec Shengli Petroleum Engineering Co., Ltd.)
　　5. Green design and manufacturing technology and application of refrigeration household appliances.
　　Completed by: Yin Fengfu (Technology R&D Center of Haier Group)
　　　　　　Liu Zhenyu (Haier Group Technology Research and Development Center)
　　　　　　Li Biao (Haier Group Technology Research and Development Center)
　　　　　　Li Yuxiang (Haier Group Technology Research and Development Center)
　　　　　　Li Hongtao (Haier Group Technology Research and Development Center)
　　　　　　Zhou Xiaodong (Haier Group Technology Research and Development Center)
　　6, heavy oil catalytic cracking to produce more propylene and high octane gasoline new technology
　　Completed by: Yang Chaohe (China Shiyou University (East China))
　　Li Chunyi (China Shiyou University (East China))
　　Zhang Qiang (China Shiyou University (East China))
　　Shan Honghong (China Shiyou University (East China))
　　Gao Chuancheng (Shandong Hengyuan Petrochemical Company Limited)
　　Chen Xiaobo (China Shiyou University (East China))
　　7. Large-area nano-imprint lithography technology, equipment and application
　　Completed by: Lan Hongbo (Qingdao University of Technology)
　　Liu Hongzhong (Xi ‘an Jiaotong University)
　　Jiang Weitao (Xi ‘an Jiaotong University)
　　Zhang Xiufang (Qingdao Jiaxing Jingdian Technology Co., Ltd.)
　　Li Xiaoyan (Qingdao Jiaxing Jingdian Technology Co., Ltd.)
Third prize (2 items)
　　1, the key technology of new anti-infectious diseases in veterinary medicine creation.
　　Completed by: Hao Zhihui (Qingdao Agricultural University)
　　Hu Songhua (Zhejiang University)
　　Mu Xiang (Beijing Agricultural College)
　　Zheng Jifang (Lanzhou Institute of Animal Husbandry and Veterinary Medicine, China Academy of Agricultural Sciences)
　　Li Dinggang (Baoding Jizhong Drug Co., Ltd.)
　　Xu Xiaoxi (Jiangxi Zhongcheng Chinese Medicine Raw Materials Co., Ltd.)
　　2. Development and industrialization of tirofiban hydrochloride and its series preparations.
　　Completed by:
　　Zhang Zeping (Lunan Pharmaceutical Group Co., Ltd)
　　Shiqide (Shandong New Age Drug Co., Ltd.)
　　Wang Haixin (Lunanbeite Pharmaceutical Co., Ltd.)
　　Wang Zhaoqin (Lunanbeite Pharmaceutical Co., Ltd.)
　　Yao Jingchun (Lunan Pharmaceutical Group Co., Ltd.)
　　Liu Bingguang (Lunan Pharmaceutical Group Co., Ltd.)
Shandong province science and technology progress award
First prize (19 items)
　　1. Breeding, popularization and application of a new wheat variety Yannong 5158 with high yield, wide adaptability and high quality.
　　Completed by: Yantai Academy of Agricultural Sciences, Shandong Province.
　　Anhui new century agriculture co., ltd
　　Completed by: Wang Jiangchun, Zhang Shanyong, Liu Xueqing, Xin Qingguo, Yin Yan, Huang Daifeng, Chen Kang, Liu Weizheng, Sun Nina, Ding Xiaoyi, Ding Kai and Yan Meiling.
　　2. Breeding of new onion, ginger and garlic varieties and application of new technologies for safe and efficient production.
　　Completed by: Vegetable and Flower Research Institute of Shandong Academy of Agricultural Sciences.
　　Chinese Academy of Agricultural Sciences Institute of Vegetables and Flowers
　　Northwest A&F University
　　Liaoning Academy of Agricultural Sciences
　　Nanjing Agricultural University
　　Completed by: Chen Yunqi, Wu Xiong, Cheng Zhihui, Li Xixiang, Cui Lianwei, Kong Suping, Liu Bingjiang, Gao Limin, Fang Yong, Huo Yumeng, Yang Yanyan, Liu Bo.
　　3. Research and application of disaster mechanism and reduction prevention and control technology of fruit tree moth.
　　Completed by Institute of Plant Protection, Shandong Academy of Agricultural Sciences
　　Shandong Agricultural University
　　Qingdao agricultural university
　　shandong institute of pomology
　　China Agricultural University
　　Henan University of Science and Technology (HAUST)
　　Completed by: Yu Yi, Ren Fengshan, Li Lili, Du Fengpei, Li Dingxu, Xu Yongyu, Sun Ruihong, Men Xingyuan, Zheng Changying, Li Ruijun, Zhang Sicong and Zhang Ansheng.
　　4. Key technologies for efficient production of edible fungi from breeding wastes and comprehensive utilization of mushroom residues.
　　Completed by: Institute of Agricultural Resources and Environment, Shandong Academy of Agricultural Sciences
　　Shandong Agricultural University
　　Shandong province agriculture technology popularizing station
　　Shandong Qihe Biotechnology Co., Ltd.
　　Shandong zuotianshi biology science and technology co., ltd
　　Completed by: Gong Zhiyuan, Wan Luchang, Pang Maowang, Han Jiandong, Ren Haixia, Yao Qiang, Gao Xia, Huang Chunyan, Ren Pengfei, Jia Le, Li Jin and Song Yisheng.
　　5. Research on key technologies and industrialization demonstration of high-quality and efficient production of beef cattle.
　　Completed by: Animal Husbandry and Veterinary Research Institute of Shandong Academy of Agricultural Sciences.
　　Shandong Agricultural University
　　Shandong province animal husbandry station
　　Linyi huier animal nutrition co., ltd
　　Shandong Wudi Huaxing Bohai Heiniu Seed Industry Co., Ltd.
　　Completed by: Wan Fachun, Liu Guifen, Liu Xiaomu, Hu Hongjie, Tan Xiuwen, Jiang Shuzhen, Song Enliang, Cheng Haijian, Zhao Hongbo, You Wei, Shao Zhumin, Yang Zhangang.
　　6. Pathogenic research and prevention and control technology of four main virus diseases in poultry.
　　Completed by: Poultry Research Institute of Shandong Academy of Agricultural Sciences
　　Shandong province animal epidemic disease prevention Yu control center
　　China Agricultural University
　　institute of microbiology, chinese academy of sciences
　　Ganyuanhao biology co., ltd
　　Completed by: Qin Zhuoming, Fu Tian Lin, Zhang Guozhong, Ai Wu, Xu Huaiying, Liu Wenjun, Wang Youling, Huang Bing, Qi Lihong, Liang Junwen, Yue Jianxin and Huang Dihai.
　　7. Technical system of marine monitoring buoy and its engineering application in national marine monitoring network.
　　Completed by: Institute of Marine Instrumentation, Shandong Academy of Sciences
　　Chinese Marine University
　　Completed by: Liu Shixuan, Wang Juncheng, Li Min, Fan Xiutao, Zhang Shuwei, Guo Fadong, Pei Liang, Chen Shizhe, Zhao Jinping, Wang Xiaoyan, Bu Zhaopeng and Qi Yong.
　　8. Application research and industrialization of high-performance optical fiber devices and sensor networks in oil and gas field.
　　Completed by: Laser Research Institute of Shandong Academy of Sciences.
　　CNOOC Donghai Xihu Oil and Gas Operation Company
　　China Petrochemical Shengli Oilfield Petroleum Engineering Technology Research Institute
　　Completed by: Wang Chang, Guo Shisheng, Sun Baoquan, Liu Xiaohui, Qi Haifeng, Sun Zhihui, Lu Jingsheng, Ni Jiasheng, Yang Ping, Li Shujuan, Song Zhiqiang and Shang Ying.
　　9, large belt conveyor system security key technology
　　Completed by Libo Heavy Industry Technology Co., Ltd.
　　Shandong University of Science and Technology
　　China Mining University
　　Taian yingdili electromechanical technology co., ltd
　　Completed by: Zhou Manshan, Zhang Yuan, Zhou Gongbo, Li Wei, Xiao Linjing, zhangxin, Han Rujun, Yu Tao, Meng Qingrui, Sun Hui, Sun Binwu and Zhang Hua.
　　10, coal mine safety comprehensive monitoring system based on optical fiber sensing network.
　　Completed by: Laser Research Institute of Shandong Academy of Sciences.
　　　　　　　Yankuang group co., ltd
　　　　　　　Shandong languang software co., ltd
　　　　　　　Yanzhou coal industry co., ltd
　　　　　　　Shandong weiguanggan electronics co., ltd
　　Completed by: Zhao Zengyu, Liu Tongyu, Gong Zhijie, Lu Xinming, Ma Junpeng, Song Guangdong, Xie Qiangzhen, Deng Xiaolin, Yan Qinyun, Hao Yingge, Zhao Yanjie and Zhao Lin.
　　11. R&D and industrialization of flame retardant automobile interior leather
　　Completed by: Yantai University
　　　　　　　Shandong quanjie leather institute co., ltd
　　Haining sende leather co., ltd
　　Completed by: Wang Quanjie, Duan Baorong, Tang Zhihai, Ding Haiyan, Zhang Mengmeng, Hou Lijie, Wang Yanqing and Liu Guilin.
　　12, efficient large-scale coal water slurry gasification technology
　　Completed by Yankuang Group Co., Ltd.
　　　　　　　East China University Of Science and Technology
　　Completed by: Zhang Minglin, Yu Guangsuo, Lu Wenxue, Liu Haifeng, King Kong, Zhou Zhijie, Jin Junjie, Dai Zhenghua, Zhu Qingrui, Wang Yifei, Guo Baogui, Wang Fuchen.
　　13. Data accumulation, regularity and shared service of marine environmental corrosion of materials
　　Completed by: Qingdao Institute of Marine Corrosion, Iron and Steel Research Institute.
　　University of Science and Technology Beijing (USTB)
　　Qingdao gang Yan na ke detection protection technology co., ltd
　　Completed by: Li Xiaogang, Han Bing, Wu Junsheng, Yang Chaohui, Cheng Xuequn, Huang Guiqiao, Xiao Kui, Zhang Bo, Du Cuiwei, Dong Chaofang, Ding Guoqing, Jin Gao.
　　14. Development and industrialization of high-grade CNC super-large marine plate bending machine
　　Completed by: Taian Hualu Forging Machine Tool Co., Ltd.
　　Nanjing University of Science and Technology
　　Completed by: Liu Qingyin, Wu Kai, Qian Jianxin, Tian Yanxin, Wang Xiaojian, Chang Xin, Sun Yu, Liu Jingshuo, Cheng Guoren, Zhu Zongqiang and Fan Dianming.
　　15. Key technologies and industrialization of large-scale energy-saving and environment-friendly magnetic levitation centrifugal central air conditioning.
　　Completed by: Qingdao Haier Air Conditioning Electronics Co., Ltd.
　　University of Shanghai for Science and Technology
　　Completed by: Guo Defeng, Zhang Hua, Wang Li, Yang Baolin, Chea Chang, Shi Bin, Zhu Lianfu, Chen Xi, Wang Tiewei and Wang Xiyuan.
　　16, thyroid stimulating hormone (TSH) regulation of cholesterol metabolism mechanism and clinical application.
　　Completed by: Shandong Provincial Hospital
　　Completed by: Zhao Jiajun, Song Yongfeng, Xu Chao, Guan Qingbo, Zhang Haiqing, Zhang Bingchang, Yu Yong, Liu Jun, Tian Xingsong, Yu Chunxiao, Zhang Xu and Gao Ling.
　　17, non-small cell lung cancer diagnosis and treatment of key technologies and clinical application.
　　Completed by: Second Hospital of Shandong University
　　Completed by: Zhao Xiaogang, Du Jiajun, Dong Xiaopeng, Zhai Guangxi, Dong Wei, Wang Guanghui, Peng Chuanliang, Cong Bo and Sun Qifeng.
　　18, early detection and reasonable evaluation of traditional Chinese medicine hepatotoxicity technology platform construction and its scientific application.
　　Completed by: Shandong Institute of Traditional Chinese Medicine
　　China Pharmaceutical University
　　Shandong university of traditional Chinese medicine
　　Peking University
　　Completed by: Sun Rong, Zhang Luyong, Zhang Chengbo, Zhang Qingying, Lu Lili, Jiang Zhenzhou, Li Xiaoyu, Mao Jinlong, Li Xiaoyao, Zhang Limei, Huang Wei, Zou Jingwei.
　　19, proton pump inhibitor drug new preparation system construction and broaden the clinical indications and scale industrialization.
　　Completed by: Shandong Luoxin Pharmaceutical Group Co., Ltd.
　　Shandong yuxin drug co., ltd
　　Shandong hengxin drug co., ltd
　　Completed by: Li Xiaofeng, Wang Jun, Guo Zhongming, Wang Lianhui, Yang Lijuan, Liu Meijuan, Feng Changyun, Zhang Xianzhen, Yang Leixiang, Zhang Mingfa, Zhao Jinlong and Li Zhen.
Second prize (55 items)
　　1. Breeding of Jigu series varieties and light, simple and efficient cultivation techniques.
　　Completed by: Crop Research Institute of Shandong Academy of Agricultural Sciences
　　Completed by: Guan Yan ‘an, Yang Yanbing, Qinling, Zhang Huawen, Wang Hailian, Chen Erying, Du Jinzhe, Liu Bin and Chen Guiling.
　　2. Collection, preservation and development of drought-resistant and salt-tolerant crop germplasm resources in Shandong coastal areas.
　　Completed by Shandong Agricultural Germplasm Resource Center.
　　Completed by: Ding Hanfeng, Zhang Xiaodong, Yu Hua, Kong Weiguo, Li Nana, Li Runfang, Zhang Yu, Wang Junfeng and Dong Wang.
　　3. Research and application of key technologies for intensive and efficient seedling raising of vegetables.
　　Completed by: Shandong Agricultural University
　　　　　　　Shandong Anxin seedling co., ltd
　　　　　　　Shandong shangdao biology science and technology co., ltd
　　　　　　　Shandong province agriculture technology popularizing station
　　　　　　　Zhejiang boren industry & trade co., ltd
　　　　　　　Weifang runpeng seedling co., ltd
　　Completed by: Wei Min, Gao Zhongqiang, Feng Xihong, Han Jishu, Yang Fengjuan, You Kuangbiao, Wu Jinjuan, Xia Xueyi and Hao Guofang.
　　4. Breeding of new blueberry varieties with high irrigation and efficient cultivation techniques.
　　Completed by: shandong institute of pomology
　　Completed by: Liu Qingzhong, Wei Hairong, Zhao Hongjun, Xin Chen, Wang Jiawei, Zong Xiaojuan, Wang Jianghui, Zhang Daohui, Tan Yue.
　　5. Research and application of the evolution law of dominant cotton regions and high-yield and high-efficiency cultivation techniques in Shandong Province.
　　Completed by: Shandong Cotton Production Technical Guidance Station
　　Heze Jin Zhengda ecology engineering co., ltd
　　Shandong cotton research center
　　Completed by: Zhao Hongliang, Yu Qianlin, Li Yuepeng, Luo Zhen, Sun Weiqi, Xu Qinqing, Sun Xuezhen, Zhang Shaohong and Wang Yan.
　　6. Research and application of disaster mechanism of root maggots of leek and garlic and key technologies of green prevention and control.
　　Completed by: Shandong Agricultural University
　　Weifang vocational college
　　Taian agricultural science study institute
　　Jining agricultural science study institute
　　Completed by: Xue Ming, Mu Wei, Liu Feng, Ma Jingyu, Wang Chengxiang, Ma Chong, Zhou Xianhong, Liu Jianping and Xu Jiali.
　　7. Innovation and industrialization of key technologies for safe and efficient feed for pigs and poultry.
　　Completed by: Shandong New Hope Liuhe Group Co., Ltd.
　　Agriculture Department Feed Quality Supervision and Inspection Testing Center (Ji ‘nan)
　　Completed by: Lv Mingbin, Li Xiangming, Guo Jiyuan, Yan Lei, Wang Yongxiu, Li Dianchang, Huang He, Sui Li, Lu Zunzhou.
　　8. Research and application of key technologies of amino acid balance in dairy cows’ diets.
　　Completed by: Shandong Agricultural University
　　Completed by: Lin Xueyan, Wang Zhonghua, Hou Qiuling, Yan Zhengui, Hu Zhiyong, Wang Yun and Shi Kerong.
　　9. Screening of natural drugs against bacterial resistance and research and development of products
　　Completed by Shandong Veterinary Medicine Quality Inspection Institute.
　　Shandong huaerkang veterinary medicine co., ltd
　　Completed by: Gao Yingchun, Zhang Chuanjin, Wei Xiuli, Yang Xiu Town, Su Mei, He Xinli, Wang Tinghong, Feng Tao, Lu Qingquan.
　　10, Platycladus orientalis germplasm resources evaluation, seed selection and cultivation techniques
　　Completed by: Shandong Agricultural University
　　Pingyin county forestry bureau
　　Zaozhuang forestry bureau
　　Zibo Forestry Bureau
　　Taian Taishan forestry science study institute
　　Completed by: Xing Shiyan, Wang Yushan, Liu Weifeng, Lu Benrong, Zhu Wei, Li Jihong, Sang Yalin, Sun Zhongxu and Liu Zhaoquan.
　　11. Construction and application of environmental safety assessment and monitoring system for shellfish culture in key sea areas of Yellow Sea and Bohai Sea.
　　Completed by: Shandong Institute of Marine Resources and Environment
　　First Institute of Oceanography, State Oceanic Administration
　　Shandong province fishery technology popularizing station
　　Shandong province marine biology research institute
　　Completed by: Zhang Limin, Ma Jianxin, Xia Tao, Song Xiukai, Li Lujing, Sun Fuxin, Ma Yuanqing, Xu Yingjiang, Liu Aiying.
　　12, Stichopus japonicus ecological seed cultivation and healthy breeding technology establishment and application.
　　Completed by: Shandong Institute of Marine Biology
　　Huanghai Fisheries Research Institute, Chinese Academy of Fishery Sciences
　　Shandong haodangjia ocean development co., ltd
　　Shandong Anyuan aquatic products co., ltd
　　Dongying haiyue aquatic products technology co., ltd
　　Shandong haiyibao aquatic products co., ltd
　　Yantai haiyi seedling industry co., ltd
　　Completed by: Li Chenglin, Hu Wei, Chen Siqing, Sun Yongjun, Zhao Bin, Changqing, Zou Ange, Han Sha, Wang Liang.
　　13, jack-up platform structure safety technology research and development and application.
　　Completed by: China Shiyou University (East China)
　　Sinopec Shengli Petroleum Engineering Co., Ltd. Drilling Technology Research Institute
　　Completed by: Cao Yuguang, Zhang Shihua, Fan Dunqiu, Huang Xiaoguang, Meng Zhanbin, Shi Yongjin, Sun Yongtai, Sun Xiaoyu and Tian Haiqing.
　　14. R&D and application of new technologies for hydraulic gates and opening and closing systems
　　Completed by: Shandong Water Conservancy Survey and Design Institute
　　Zhongshui North Survey Design Research Co., Ltd.
　　Shanghai survey design & research institute co., ltd
　　Completed by: Du Peiwen, Zhu Fengshan, Zheng Xianghui, Jia Yongming, Zhang Zhengwei, Xu Zhigang, Fan Zhiguo, Cheng Guodong and Zhu Lin.
　　15. Research and application of key technologies for large-scale development of low-grade resources in gold mines.
　　Completed by: Sanshandao Gold Mine of Shandong Gold Mining (Laizhou) Co., Ltd.
　　China Mining University
　　Completed by: Hua Haiyang, Cao Yijun, Wang Baosheng, Xie Minxiong, Zhang Haijun, Qu Gangmin, Ma Zilong, Li Tao and Lu Xintao.
　　16, ilmenite chemical composition standard material development
　　Completed by: Shandong Institute of Geological Sciences
　　Completed by: Hong Fei, Yu Xuefeng, zhaowei, Wang Qing, Mao Meiqiao, Zhang Hall, Cheng Xuehai, Yuan Jiayi, Lv Zhensheng.
　　17, universal collaborative geographic information public service key technologies and platform applications.
　　Completed by: Shandong Institute of Land Surveying and Mapping
　　Wuhan University
　　Beijing Siweitu New Technology Co., Ltd.
　　Completed by Xiang Hengmao, Kong Zhaohui, Wang Yandong, Mao Jijun, Zhang Wei, Sun Jiuhu, Wang Feng, Zhong Jia, Han Haifeng.
　　18, Yanzhou mining area Ordovician limestone high confined water coal seam safety mining key technology research and application.
　　Completed by: Yanzhou Coal Industry Co., Ltd.
　　China University of Mining and Technology (Beijing)
　　China Mining University
　　Completed by: Cao Dingtao, Wu Qiang, Jiang Zhenquan, Zhu Shuyun, Guan Yunzhang, Liu Ruixin, Hu Dongxiang, Zuo Jinzhong and Xu Yi.
　　19, gravel reservoir seismic description technology and supporting application.
　　Completed by: Geophysical Research Institute of Shengli Oilfield Branch of China Petrochemical Company.
　　Completed by: han hongwei, Yu Zhengjun, Lu Shenqiang, Kong Shengwu, Li Jiguang, Miao Yongkang, Zhu Yingke, Pan Xingxiang, Xia Jizhuang.
　　20. Key technologies of seismic sedimentology and their large-scale application in oil and gas reservoir exploration and development.
　　Completed by: China Shiyou University (East China)
　　China Petrochemical Company Shengli Oilfield Branch Geophysical Research Institute
　　China Petrochemical Company Shengli Oilfield Branch Xianhe Oil Production Plant
　　Completed by: Lin Chengyan, Zhang Xianguo, Dong Chunmei, Ren Lihua, Wang Yanguang, Zhang Junhua, Jiao Hongyan, Song Weiqi and Zhang Tao.
　　21, citric acid efficient biological manufacturing technology development and industrialization
　　Completed by Weifang Yingxuan Industrial Co., Ltd.
　　Shandong province food fermentation industry research and design institute
　　Institute of Biology, Shandong Academy of Sciences
　　Completed by: Liu Jianjun, Li Shiyong, Ma Yaohong, Zhang Chuanhui, Li Qiushun, Zhao Xiangying, Li Jian, Ma Qinyuan, Qiao Jun.
　　22. Research and application of detection technology for chemical additives and drug residues in food.
　　Completed by: Shandong Institute of Food and Drug Inspection
　　Completed by: Jonathan Zhu, Alvin Wong, Shi Guosheng, Liu Yanming, Shi Feng, Zhang Xiqi, Zhang Hui, Hu Mei and Shen Zhonglan.
　　23. Key technologies and industrialization of high-efficiency self-cleaning functional cotton fabrics.
　　Completed by Lutai Textile Co., Ltd.
　　Jiangnan University/ Southern Yangtze University
　　Shandong university of technology
　　Completed by: Zhang Jianxiang, Jiang Xue, Huang Dan, Liu Zibin, Du Jinmei, Ni Aihong, Wang Hongbo, Wang Weiwei and Cai Haijuan.
　　24. Screening of marine microalgae with high DHA production and demonstration project of cleaner production
　　Completed by: Qingdao Langyatai Group Co., Ltd.
　　qingdao institute of biomass energy and bioprocess technology, chinese academy of sciences
　　Completed by: Cui Qiu, Li Yueming, Song Xiaojin, Xu Jianchun, Li Xia, Feng Yingang, Xia Xiuluan, Tan Yanzhen and Gao Mang.
　　25, based on biomass nutrients and biological sterilization disease-resistant and efficient urea production system construction and industrialization.
　　Completed by: Shandong Runyin Biochemical Co., Ltd.
　　China Academy of Agricultural Sciences Institute of Agricultural Resources and Agricultural Regionalization
　　Shandong enbao biology science and technology co., ltd
　　Completed by: Meng Guangyin, Lin Jiong, He Shuwen, Zhang Chengsheng, Wang Zhiyong, Li Qiang, Chen Zhenwei, Yuan Liang and Zhang Shoufu.
　　26. Construction and industrialization of a new preparation system of cefoxitin sodium based on key technologies and pharmaceutical preparations.
　　Completed by: Shandong Hengxin Pharmaceutical Co., Ltd.
　　Shandong yuxin drug co., ltd
　　Shandong luoxin pharmaceutical group co., ltd
　　Completed by: Chen Yu, Song Liangwei, Wang Ping, Song Lili, Li Fan, Ruan Chaobin, Liu Yanzhen, He Yaguan and Chai Qian.
　　27. Construction and industrialization of new preparation system of environmental protection and energy-saving glass fiber based on boron-free and fluorine-free
　　Completed by Taishan Glass Fiber Co., Ltd.
　　Completed by: Tang Zhiyao, Li Yongyan, Zhang Degang, Liu Honggang, Yang Hao, Wang Jiafang, Ming Licheng, Xu Yanchao and Liu Lifeng.
　　28, silicon carbide composite ceramic material preparation technology and application
　　Completed by Shandong Baona New Materials Co., Ltd.
　　Shandong University
　　Completed by: Zhang Yujun, Zhaomin Li, Zhai Yanxia, Li Wenjie, Sun Haibin, Li Qisong, Liu Huan, Song Jianfeng.
　　29. Development and application of complete sets of technologies for treating sour gas containing sulfur in refining and chemical industry.
　　Completed by Qilu Branch of China Petrochemical Co., Ltd.
　　Shandong Qilu keli chemical industry research institute co., ltd
　　Completed by: Da Jianwen, Liu Aihua, Xu Xingzhong, Liu Jianli, Tao Weidong, Xu Jinshan, Wang Jianhua, Gao Buliang and Liang Yingjie.
　　30. Construction, development and application of new process system based on deep extraction of complex gold and silver concentrate and green industrialization.
　　Completed by: Jinjiling Gold Mine of Zhaojin Mining Co., Ltd.
　　Completed by: Li Xueqiang, Xu Zhongmin, Weng Zhanping, Gao Lifa, Shen Shubao, Liu Zhixin, Cheng Tai, Yang Guangjie and Guo Hongzhu.
　　31, near net shape beam blank continuous casting process technology integration and innovation
　　Completed by Laiwu Iron and Steel Group Co., Ltd.
　　Completed by: Li Hongjian, Wu Guangjun, Wang Zhongxue, Guo Weida, Zhang Jie, Lu Bo, Ning Wei, Feng Qichao and Zhang Haibo.
　　32. Development and application of high-efficiency switched reluctance motor drive system
　　Completed by Shandong Kehui Electric Power Automation Co., Ltd.
　　Shandong university of technology
　　Shandong rifa textile machinery co., ltd
　　Completed by: Xiong Lixin, Jia Mingquan, Bian Dunxin, Zhao Tingting, Sun Qingjun, Xu Bingyin, Zhang Mingkui, Wang Qinchang and Cheng Jianjun.
　　　　　　　　　　　　　　　　
　　
　　33, electric vehicle charging and replacing facilities efficiency improvement and operation technology research and application.
　　Completed by: State Grid Shandong Electric Power Company
　　Shandong Electric Power Research Institute
　　Shandong luneng intelligent technology co., ltd
　　Completed by: Cai Guangdao, Gao Yuming, Li Jianxiang, Zhang Jian, Justin, Zhang Huadong, Guo Liang, Song Haifeng and Liu Haibo.
　　34, insulator string detection robot
　　Completed by: State Grid Shandong Electric Power Company
　　State Grid Shandong Electric Power Company Electric Power Science Research Institute
　　Shandong luneng intelligent technology co., ltd
　　Completed by: Kuoray, Han Lei, Yong Jun, Wang Chuanqing, Ren Jie, Sun Yutian, Shen Qinghe, Zhang Feng and Cao Lei.
　　35, including large-scale wind power grid generation scheduling mode and key technology research and application.
　　Completed by: Shandong Electric Power Dispatching and Control Center
　　Tsinghua University
　　Beijing Qing da ke yue technology co., ltd
　　Completed by: Qiu Xizhao, Zhong Haiwang, Xia Qing, Yang Minghui, Zhang Jian, Zhang Guoqiang, Guo Shaoqing, Yuan Sen and Cheng Yan.
　　36, underground engineering through water-rich soft stratum major disaster control technology.
　　Completed by: Shandong University
　　China railway 19 th bureau group 5 th engineering co., ltd
　　Shaanxi Luqiao group first engineering co., ltd
　　Ji’ nan liwen geotechnical engineering co., ltd
　　Completed by: Zhang Qingsong, Liu Rentai, Zhang Xiao, Lin Chunjin, Wang Chaochao, Yang Weimin, Li Liping, Fan Yanxiang, Hu Wei.
　　37, urban water supply system monitoring and early warning of sudden pollution and emergency treatment technology research and application.
　　Completed by: Jinan Water Supply and Drainage Monitoring Center
　　Tsinghua University
　　Ji’ nan Qingyuan water group co., ltd
　　Ji’ nan quancheng water co., ltd
　　Shenzhen qingshijie technology co., ltd
　　Hangzhou lvjie water technology co., ltd
　　Shandong Shanda huate technology co., ltd
　　Completed by: Jia Ruibao, Zhang Xiaojian, Sun Shaohua, Chen Chao, Pan Zhangbin, Ma Zhongyu, Song Wuchang, Liu Minghui and Cui Pengwei.
　　38. Innovative technology and engineering application of point-supported glass curtain wall and lighting roof
　　Completed by: Tianyuan Construction Group Co., Ltd.
　　Tsinghua University
　　Harbin Institute of Technology
　　China construction science research institute
　　Shandong University of Science and Technology
　　China Wuzhou Engineering Design Group Co., Ltd.
　　Shenzhen mainuo curtain wall technology co., ltd
　　Completed by: Liu Jun, Wang Yuanqing, Wu Yue, Liu Jian, Shi Yongjin, Wang Lai, An Baiping, Ding Dayi, Liao Dongfan.
　　39. Research, development and application of laying and discharging technology and deep-water laying and discharging equipment in severe working conditions of Yangtze River deepwater channel regulation project.
　　Completed by: No.2 Engineering Co., Ltd. of China Communications No.1 Navigation Bureau.
　　Completed by: Liu Dejin, Qu Lili, Feng Haibao, Xu Shanzhong, Ma Zongtian, Yang Ruiliang, Sun Liang, Fu Dawei, Zhang Qingwen.
　　40, the Yellow River Delta asphalt pavement water damage fluid-solid coupling mechanism, damage assessment method and prevention technology.
　　Completed by: Shandong Binzhou Highway Engineering Corporation
　　Shandong University
　　Highway Science Research Institute of Ministry of Transport
　　Completed by Cui Xinzhuang, Wang Tao, Qi Chunguang, An Zhicun, Guan Yanhua, Chang Chengli, Ding Guanxu, Liu Yanbing, Zhang Jiong.
　　41, high concentration organic wastewater catalytic wet oxidation treatment technology
　　Completed by: Wanhua Chemical Group Co., Ltd.
　　Dalian Institute of Chemical Physics, Chinese Academy of Sciences
　　Completed by: Sun Chenglin, Hua Weiqi, Wei Huangqi, Zhang Hongke, He Songbo, Yu Tianyong, Liu Xiaogao, Hu Zhan and zhaonan.
　　42, functional imaging and molecular targeted guided precise radiotherapy of chest tumor.
　　Completed by: Shandong Institute of Cancer Prevention and Treatment.
　　Completed by: Yuan Shuanghu, Jiang Xiaodong, Xia Bing, Hu Xudong, Li Minghuan, Liu Ning, Yu Qingxi, zhaowei and Zhou Bo.
　　43. Neuroinflammatory mechanism of Alzheimer’s disease and new targets of drug intervention.
　　Completed by: Qingdao Municipal Hospital
　　Completed by: Tan Lan, Yu Jintai, Wang Ping, Tan Mengshan, Miao Dan and Zhang Qun.
　　44, the basic and clinical application of chronic liver disease related to hepatitis B virus.
　　Completed by: No.88 Hospital of PLA
　　Liberation Army No.302 Hospital
　　Peking University Health Science Center
　　Completed by: Shang Qinghua, Wang Yongqing, Zhang Zheng, Liu Xueen, Zhang Wei, Jin Lei, Zhuang Hui, Yu Jianguo and Zhang Guangshu.
　　45. Individualized carotid endarterectomy and its perioperative complications prevention strategies.
　　Completed by: Liaocheng People’s Hospital
　　xuanwu hospital capital medical university
　　Tang Dou Hospital of the Fourth Military Medical University of Chinese People’s Liberation Army
　　Completed by: Wang Jiyue, Zhang Liyong, Lin Kai, Hao Jiheng, Jiao Liqun, Chen Yanfei, Ling Feng, Zhao Zhenwei, Deng Jianping.
　　46, the establishment and application of key technology of minimally invasive surgical closure of structural heart disease.
　　Completed by: Shandong Provincial Hospital
　　Completed by: Li Hongxin, Zhang Haizhou, Guo Wenbin, Liang Fei, Zou Chengwei, Yuan Guidao, Wang Zhengjun and Zhang Wenlong.
　　47. Dynamic study and application of laryngeal function preservation and reconstruction and oncogene serology in laryngeal cancer
　　Completed by: Yantai Yuhuangding Hospital
　　Completed by: Song Xicheng, Zhang Hua, Yan Sun, Wang Li, Liu Zhonglu and Rebecca.
　　48. Evaluation technology and application of cardiovascular activity of traditional Chinese medicine based on zebrafish model
　　Completed by: Institute of Biology, Shandong Academy of Sciences
　　kunming institute of botany, chinese academy of sciences
　　Shandong University
　　Shandong wohua medical technology co., ltd
　　Shenyang Pharmaceutical university
　　Completed by: Liu Kechun, He Qiuxia, Han Liwen, Peng Weibing, Li Xiaoli, Chen Xiqiang, Zang Hengchang, Zeng Yingzi and Yang Yongping.
　　49. Etiological equivalent analysis and clinical application of pulmonary diseases
　　Setting: Affiliated Hospital of Shandong University of Traditional Chinese Medicine.
　　Completed by: Zhang Wei, Zhu Xue, Chen Xianhai, Jia Xinhua, Zhang Xinyue, Zhang Cai Qing, Ding Meng, Tian Xue and Zhang Yang.
　　50. New preparation system and industrialization of salbutamol sulfate aerosol based on tetrafluoroethane replacing Freon.
　　Completed by Shandong Jingwei Pharmaceutical Co., Ltd.
　　Shanghai Food and Drug Inspection Office
　　Shanghai huarui aerosol co., ltd
　　Completed by: Li Tiejun, Yu Yuntao, Zhang Zhichao, Chen Guiliang, Zhang Yan and Wang Zhenyong.
　　51, L- arginine clean production process research and development
　　Completed by Shandong Fufeng Fermentation Co., Ltd.
　　Shandong University
　　Qilu university of technology
　　Shandong fufeng biotechnology development co., ltd
　　Completed by: Liu Xinli, Hu Wei, Li Deheng, Zhao Lin, Feng Zhenquan, Tang Yongqiang, Li Shubiao, Zhao Lankun and Liu Yuantao.
　　52, transgenic corn environmental safety monitoring technology and application
　　Completed by Institute of Plant Protection, Shandong Academy of Agricultural Sciences
　　Completed by: Lu Xingbo, Sun Hongwei, Fan Li, Yang Shuke, Yue Aidong, Xu Xiaohui, Gao Rui, Yuan Lei and Feng Liping.
　　53. Research and application of rapid detection technology of pesticide residues in vegetables based on biosensor.
　　Completed by: Shandong University of Technology
　　Zibo vegetables office
　　Beijing Qiangsheng Minghe Science and Technology Development Co., Ltd.
　　Shandong anbo instrument co., ltd
　　Completed by: Sun Xia, Guo Yemin, Wang Xiangyou, Xu Jianguang, Zhao Wenping, Wang Shujun, Ding Yan, Liu Shanfei and Qi Bin.
　　54. Technological innovation system of brown algae bio-industry
　　Completed by: Qingdao Mingyue Seaweed Group Co., Ltd.
　　55, drug research and development technology innovation platform (enterprise technology innovation)
　　Completed by Disha Pharmaceutical Group Co., Ltd.
Third prize (36 items)
　　1. Breeding of disease-resistant and storable tomato varieties and innovation and application of high-efficiency cultivation techniques.
　　Completed by Shouguang New Century Seedling Co., Ltd.
　　Northeast agricultural university
　　Shandong province vegetables cultivation engineering technology research center
　　Completed by: Hu Yongjun, Xu Xiangyang, Sang Yizhen, Jiang Jingbin, Tian Subo, Zhang Yunming.
　　2. Breeding of new peach varieties with high quality and integration of key cultivation techniques.
　　Completed by Weifang Academy of Agricultural Sciences, Shandong Province
　　Completed by: Lin Yundi, Wei Yongyang, Zhao Qingzhu, Han Xia, Zhang Dongqi, Gao Jing
　　3. Development and application of key technology of new degradable coated controlled release fertilizer.
　　Completed by: Jin Zhengda Ecological Engineering Group Co., Ltd.
　　Dezhou Jin Zhengda ecology engineering co., ltd
　　Jin Zhengda Notaire chemistry co., ltd
　　Completed by: Zhang Qiang, Wang Huaili, Liu Wenlong, Dong Yan, Li Jiguo and Hu Bin.
　　4. Research and application of pathogen identification and integrated prevention and control technology of peanut diseases in Shandong.
　　Completed by Institute of Plant Protection, Shandong Academy of Agricultural Sciences
　　Shandong peanut institute
　　Fujian Kaili biology products co., ltd
　　Taian agricultural science study institute
　　Yantai agriculture technology popularizing center
　　Completed by: Li Changsong, Chi Yucheng, Zhang Yueli, Jaco, Xu Manlin and Liu Tingli.
　　5. Research and application of rubber recycled concrete to improve the durability of small and medium-sized hydraulic structures.
　　Completed by: Shandong Institute of Water Conservancy.
　　Shandong jiaotong university
　　Beijing University of Technology
　　Completed by: Wang Keliang, Cheng Suzhen, Li Yue, Xu Shangjie, Liu Ling, Hu Tingzheng.
　　6. Development and industrialization of high-speed PON optical module technology
　　Completed by: Qingdao Hisense Broadband Multimedia Technology Co., Ltd.
　　Completed by: Zhang Hua, Zhao Qisheng, Wu Xigui, Yang Sigeng, Zhang Qiang and Xue Dengshan.
　　7. Development and application of multifunctional experimental equipment for engineering mechanics.
　　Completed by: Yantai University
　　Zhejiang University
　　Completed by Qu Shuying, Wu Jianglong, Lu Yang, Chen Yibao, Lian Jingzhou, Hou Xingmin.
　　Post-peak strength evolution law of surrounding rock in 8,000-meter deep mine roadway and its control key technology
　　Completed by Yuncheng Coal Mine, Shandong Province
　　China Mining University
　　Completed by: Wen Quan, Hu Chuanting, Wang Yingchao, Zhang Shidong, Jing Hongwen, Yue Lei.
　　9. Development and application of dynamic monitoring and risk analysis technology for rockburst disaster in deep wells.
　　Completed by: China Mining Gold Industry Co., Ltd.
　　University of Science and Technology Beijing (USTB)
　　Beijing Research Institute of Mining and Metallurgy
　　Completed by: Li Jianbo, Ji Hongguang, Yang Xiaocong, Lu Mingfu, Song Hongyu and Hu Shouquan.
　　10. Key technologies, system integration and application of comprehensive monitoring of ecology and human settlements in the Yellow River Delta.
　　Completed by: Jinan University
　　institute of geographic sciences and natural resources research,cas
　　Shandong Normal University
　　Completed by: Liu Gaohuan, Xu Zhenghe, Liu Qingsheng, Huang Fei, Chang Jun, Song Chuangye.
　　11, low permeability sandstone reservoir protection drilling and completion fluid technology
　　Completed by: Drilling Technology Research Institute of Sinopec Shengli Petroleum Engineering Co., Ltd.
　　Completed by: Tang Zhijun, Li Gongrang, Zhang Jinghui, Lan Qiang, Li Haibin and Yang Jingli.
　　12, permanent magnet synchronous inverter compressor adaptive control key technology research and industrialization.
　　Completed by Hisense (Shandong) Air Conditioning Co., Ltd.
　　Completed by: Zhang Yongliang, Yin Development, Zhao Keke, Li Benwei, Yin Xianxin and Wang Zongliang.
　　13, color corrugated cardboard key technology and production application.
　　Completed by: Shandong Century Sunshine Paper Group Co., Ltd.
　　Changle xinmai paper industry co., ltd
　　Completed by: Sheng Yongzhong, Wang Dongxing, Ci Xiaolei, Zhao Changzheng, Zhi Weixin and Zhang Zengguo.
　　14, instant rice development and industrialization technology development.
　　Completed by: Rizhao Juxian Jinsui Industry and Trade Co., Ltd.
　　Shandong academy of agricultural sciences agriculture products institute
　　Completed by: Liu Runshu, Tao Haiteng, Zong Aizhen, Dong Shuangjun, Qiu Jiying and Liu Guangyuan.
　　15. Key technologies and equipment for clean production of xylitol from corncob.
　　Completed by: Shandong Futian Pharmaceutical Co., Ltd.
　　Beijing University of Chemical Technology
　　Completed by: Yuan Qipeng, Sun Lu, Wang Xingyun, Wang Wenya, Li Shuangxi and Wang Chengfu.
　　16, peanut functional factor preparation technology research and development and application.
　　Completed by: Institute of Agricultural Products, Shandong Academy of Agricultural Sciences
　　Shandong Gaotang Lanshan Group Corporation
　　Shandong longda vegetable oil co., ltd
　　Shandong jinsheng grain and edible oil group co., ltd
　　Completed by: Xu Tongcheng, Liu Lina, Qiu Bin, Han Wei, Wang Wenliang and Liu Wei.
　　17, neonicotinoid insecticide nitenpyram technical and environmental friendly preparation of key technology development.
　　Completed by: Hailier Pharmaceutical Group Co., Ltd.
　　Qingdao university of science and technology
　　Completed by: Han Xianzheng, Wang Guangjian, Ge Yaolun, Yan Xiuwei, Chen Long Li and Wang Xu.
　　18, electronic grade solid amino trimethylene phosphonic acid preparation process.
　　Completed by Shandong Taihe Water Treatment Co., Ltd.
　　Completed by: Cheng Zhongfa, Qi Xiaojing, Wan Zhentao, Wang Yanping, Zhang Wujin, Liu Quanhua.
　　19. Development of high-purity TFT monomer liquid crystal material (nmC)
　　Completed by: Yantai Wanrun Fine Chemical Co., Ltd.
　　Completed by: Jiang Xuesong, Fu Shaobang, Yi Zhaohui, Li Yonggang, Li Peng, Li Ning.
　　20. R&D and industrialization of trifluoropropene and its series of high-performance fluorosilicone materials
　　Completed by Weihai Xinyuan Chemical Co., Ltd.
　　Shandong University
　　Jinan university
　　Completed by: Xie Lefu, Zhang Yiying, Feng Shengyu, Zhang Shuxiang, Zhang Diansong, Lv Jian.
　　21, pharmaceutical glass molding bottle key technology application research and industrial development.
　　Completed by Shandong Medical Glass Co., Ltd.
　　Completed by: Hu Yonggang, Zhang Jun, Su Yucai, Chen Gang, Wang Yuwei.
　　22, high performance perfluoroethylene propylene resin new technology research and development and industrialization
　　Completed by Shandong Huaxia Shenzhou New Materials Co., Ltd.
　　Completed by: Wang Hanli, Wang Jun, Yu Hao, Xu Qinggang, Wu Haipeng and Zhou Hongjun.
　　23, million kilowatt pressurized water reactor nuclear power plant forging main pipeline technology
　　Completed by: Yantai Taihai Manuer Nuclear Power Equipment Co., Ltd.
　　China Nuclear Power Research and Design Institute
　　Completed by: Li Zhengjun, Liu Xianghong, Zhao Tianming, Pu Xiaofen, Wang Baoping, Ren Yun.
　　24, aluminum alloy casting composite technology and equipment
　　Completed by Shandong nanshan aluminum Co., Ltd.
　　Northeastern University
　　yantai nanshan university
　　Completed by: Cheng Rence, Cui Jianzhong, Lv Zhengfeng, Qin Ke, Zhang Haitao, Yu Yujiang.
　　25, CNC automatic vertical multi-station stator winding machine
　　Completed by Shandong Zhongji Electrical Equipment Co., Ltd.
　　Completed by: Wang Weixiu, Wang Cesheng, Cheng Xuehu, Wang Xiren, Li Fuguo, Ma Chao.
　　26. Research and application of high-efficiency and energy-saving control technology and core component processing technology of crawler bulldozer.
　　Completed by: Shantui Construction Machinery Co., Ltd.
　　Completed by: Zhang Liyin, Hou Wenjun, Sean, Zhao Jianjun, Li Xuanqiu and Wan Guangqian.
　　27, new flexible high-voltage dynamic reactive power compensation device key technology research and development and industrialization application.
　　Completed by: Shandong Taikai Power Electronics Co., Ltd.
　　Completed by: Fan Deping, Feng Li, Kang Changlu, Liu Qihui, Ning Shen and Song Yuewen.
　　28, high-grade highway semi-rigid base damage theory, control method and engineering application.
　　Completed by: Shandong Institute of Transportation Science.
　　shandong jianzhu university
　　Completed by: Wei Jincheng, Wang Lin, Ma Shijie, Yu Sixin, Han Wenyang and Fu Jiancun.
　　29. Development of 160km diesel multiple unit exported to Iraq.
　　Completed by CSR Sifang Vehicle Co., Ltd.
　　Completed by Rao Zhen, Zheng Kuixian, Wang Xiaofeng, Sun Mintang, An Hailiang, Liu Xiaoguang.
　　30. Comprehensive treatment and resource utilization technology of oil sludge and sand
　　Completed by: Shandong University
　　Gudong Oil Production Plant of Shengli Oilfield Branch of China Petrochemical Co., Ltd.
　　Completed by Hou Wanguo, Tang Zhiqiang, Gao Jutong, Yan Jingen, Liu Chunbo, Huang Chun.
　　31. Study on the evolution and recombination of human enterovirus in human population and environment and the integration of new viruses.
　　Completed by Shandong Provincial Center for Disease Control and Prevention.
　　Completed by: Xu Aiqiang, Wang Haiyan, Tao Zexin, Lin Xiaojuan, Song Lizhi and Wang Suting.
　　32, bladder cancer tumor microenvironment simulation and related molecular mechanisms.
　　Completed by: Affiliated Hospital of Qingdao University.
　　No.401 hospital of PLA
　　Completed by: Niu Haitao, Wang Xinsheng, Xu Ting, Sun Lijiang, Cao Yanwei and Jiang Haiping.
　　33. Study on the application of new quantitative indexes of spiral CT in aortic dissection
　　Completed by: Qilu Hospital of Shandong University
　　Beijing anzhen hospital affiliated to Capital Medical University.
　　Completed by: Zhao Xin, Qi Ruidong, Bi Yanwen, Song Guangmin, Li Chuanbao and Sun Lizhong.
　　34. Mechanism and clinical application of diabetes affecting corneal epithelial wound healing.
　　Completed by: Qilu Hospital of Shandong University
　　Completed by: Wu Xinyi, Shi Long, Zhang Ying, Chang Yuan, Yu Xiaoming and Yang Yongmei.
　　35. Basic and clinical research on one-stage resection, functional preservation and reconstruction of hypopharyngeal cancer and cervical involved tissues.
　　Completed by: Qilu Hospital of Shandong University
　　Completed by: Xinliang Pan, Liu Dayu, Jin Tong, Lei Dapeng, Wei Dongmin and Qian Ye.
　　36, drug impurity control and evaluation of key technology platform construction and application
　　Completed by: Shandong Institute of Food and Drug Inspection
　　Completed by: Li Jun, Wang Weijian, Zhu Qingfen, Niu Chong, Zhang Zhonghu, Gong Liping.
Shandong International Science and Technology Cooperation Award
(3 persons)
　　1. Wang Dunyou
　　Country: USA
　　Partner: Shandong Normal University
　　2. Chis Eugen Jochem reinas
　　Country: Netherlands
　　Partner: Yantai CIMC Raffles Offshore Engineering Co., Ltd.
　　3. John FerAdrian Wen
　　Country: Belgium
　　Cooperative unit: Weihai Goldsun Photothermal Power Generation Equipment Co., Ltd.

　　() F10 data shows that on March 4, 2024, () theme points have been updated and adjusted:

　　Proposed layout of short drama business

　　On December 2, 2023, the announcement of the company’s change revealed that recently, some media reported that the company was involved in "short drama concept stocks". Up to now, the company’s operating income structure does not involve short drama business, and the short drama business has no impact on the company’s performance. Investors are advised to pay attention to investment risks and invest rationally. On November 7, 2023, the company disclosed on the interactive platform that short plays are a very popular content ecology recently. Our company’s business is based on content, and we are also actively deploying short play business. We have done a lot of preparatory work from script selection and creation, copyright purchase and content production. The profit model of short play business needs further verification, but we believe that the core logic of short play market is content is king. As a company operating on content and copyright, we will definitely compare ourselves.

　　Short drama business "fast burning" APP internal test

　　On December 5, 2023, the announcement of the company’s change revealed that recently, some media reported that the company involved "short drama concept stocks". Up to now, the company’s operating income structure does not involve short drama business, and the short drama business has no impact on the company’s performance. The company’s short drama business "Fast Burning" APP has completed the technical construction, and the APP is now in the internal testing stage. There are uncertainties in the online time, profit model and profitability of the "fast burning" APP. Investors are requested to objectively analyze the company’s operating environment and invest rationally. On November 7, 2023, the company disclosed on the interactive platform that short plays are a very popular content ecology recently. Our company’s business is based on content, and we are also actively deploying short play business. We have done a lot of preparatory work from script selection and creation, copyright purchase and content production. The profit model of short play business needs further verification, but we believe that the core logic of short play market is content is king. As a company operating on content and copyright, we will definitely compare ourselves.

　　NFT technology

　　In June 2022, the risk warning announcement was disclosed: Recently, some media reported that the company was involved in "NFT concept stocks". In March 2022, the company and Changsha Malanshan Investment Development and Construction Co., Ltd. jointly funded the establishment of Hunan Malanshan Tianze micro chain Technology Co., Ltd., which mainly protected and traded digital assets based on copyright content. The "China V-Chain" project is at the initial stage of development, but it has not yet opened the online trading function. Before the formal transaction, the platform also needs to obtain the network culture business license, ICP license and other related business licenses, which can only be implemented after being approved by relevant departments according to laws and regulations. At present, Hunan Malanshan Natural Selection micro chain Technology Co., Ltd. is applying for approval of related businesses, and there is still uncertainty about whether the application can be approved. Please pay attention to the risks. On January 26, 2022, the company disclosed on the interactive platform: At present, the company has used blockchain technology for copyright deposit, and we are actively paying attention to NFT technology. The online trading of video content and materials owned by the company needs NFT technology for copyright protection and development of copyright. More market value.

　　Natural Selection of micro chain —— Overall Service of Digital Rights

　　In March 2022, Zhongguang Natural Selection and Changsha Malanshan Investment Development and Construction Co., Ltd. established Hunan Malanshan Natural Selection micro chain Technology Co., Ltd. The core business of Tianxuan micro chain is to operate the overall digital rights service platform "China V-chain". By the end of 2022, there were more than 160,000 online copyright trading materials and 150,000 blockchain deposits. At present, "China V-Chain" has obtained 7 licenses required by online platforms for copyright services and transactions, and was selected as "National Radio and Television Media Convergence Growth Project in 2022". In December, 2022, Natural Selection micro chain released the "Collective Copyright Service Plan", which uses its own blockchain to form six service systems: works planning, classification and registration services, establishment of exclusive digital copyright material database, monitoring of works’ use rights throughout the network, evidence storage and notarization, automatic distribution of cases, diversified dispute resolution, authorized use and deep IP development of works, assets evaluation of works’ related rights and interests, and listing and transfer transaction services. In 2023, while continuing to serve copyright and intellectual property customers, it will also establish a V-chain copyright management SAAS system to realize the blockchain system link with relevant functional institutions and judicial acceptance, and use advanced digital intelligence, technology and accurate services to make intellectual property more valuable.

　　Comprehensive media group

　　For many years, Zhongguang Tianxuan has always adhered to the principle of "positive energy, natural selection", being the organizer of head content, an expert in vertical field and an operator of all-media content, and building a comprehensive media group with national influence. In 2021, the company has six strategic sections: content division, platform division, MCN center, film and television drama center, film center and education center, with more than 300 professional video producers, mainly engaged in the production and operation of variety shows, documentaries, film and television dramas, short videos and other video content.

　　Film and television center-investment and investment system of fine film and television

　　Since its establishment in 2018, Tianxuan Film and Television Center has produced, organized and invested in nearly 150 projects. After fully opening the paid track with differentiated and high-quality projects, it has gradually moved towards TV dramas and customized tracks for "film and television travel". In terms of online movies, box office breakthroughs have been continuously achieved, and genre innovations have been expanded: Ghost Story broke through 40 million, setting a new benchmark in the industry; the first phenomenal online movie daoist magic broadcast on dual platforms broke through 50 million, ranking among the top three in the online movie sub-account list in recent three years together with Ghost Story; in terms of online sub-account drama, a new platform record has been set year by year: Flash! Breaking the double records of iQiyi’s popularity and box office in 2022 with a sub-account box office of over 100 million yuan, Dear Mr. Lemon Essence broke through 58 million yuan, ranking first in Youku’s online sub-account drama in 2021. In TV series, Parabola of Youth inherits the spirit of China Women’s Volleyball Team and is well received. While investing and "investing", Tianxuan Film and Television Center also participated in the creation of CCTV’s large-scale documentary "For Peace", which was highly praised by China People’s Liberation Army News and Communication Center. Making the first digital film "Dragon Gate" for the world cultural heritage of Longmen Grottoes in Luoyang will be the first digital dome film of grottoes in the past decade, and it will be the first stop of the immersive cultural tour of Longmen Grottoes by means of "film and television travel".

　　Film Center —— Investment Pioneer of Sub-account Content

　　Zhongguang Natural Selection Film Center focuses on the investment of sub-account content, enters online movies and sub-account online dramas, and opens up paid tracks. In recent years, the natural selection film industry has gone from joint production TOP1 main production, and the main producer has invested in nearly 100 projects, such as Ghost Story: Human Love, daoist magic, Snake King, Flash China, Surprise Tunnel Warfare, Dismantling the Case, Murder Scene, etc., which have been launched on major video platforms one after another, among which the romantic fantasy movie Ghost Story: Human Life. As the first online movie broadcast on dual platforms, daoist magic, a fantasy martial arts action movie, ranks in the annual box office list of Aiqiyi and Tencent Video, which is the highest in the history of online movie box office. The positive energy online movie Flash China ranks first in the hot search list of Aiqiyi, second in the list of Tik TOP1 movies, the online movie of war and epidemic won the best film of the 10th Beijing International Online Movie, and mortal hero was selected as the network audio-visual quality project of SARFT. The rural comedy Erlonghu Love Story 2021 and the urban emotional drama Dear Mr. Lemon Essence are both box office champions in the same theme drama, ranking the top three in the Youku drama list and topping the Youku drama list for many times.

　　Platform Division-Pioneer of Copyright Operation

　　Zhongguang Natural Selection Platform Division has been rooted in copyright operation for many years. The two national trading platforms, Taoju Taotao and Program Purchase, focus on copyright creation, copyright protection, industrial development, copyright trading and other fields to promote the development of copyright industry, and have a good leading and exemplary role in copyright units across the country. With the ability to link the national transmission and the copyright integration of high-quality TV dramas, "Taoju Taotao" was successfully selected into the "National Radio and Television and Network Audiovisual Industry Development Project Library".